ID   HBA_HUMAN               Reviewed;         142 AA.
AC   P69905; P01922; Q1HDT5; Q3MIF5; Q53F97; Q96KF1; Q9NYR7; Q9UCM0;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   17-JUN-2020, entry version 190.
DE   RecName: Full=Hemoglobin subunit alpha;
DE   AltName: Full=Alpha-globin;
DE   AltName: Full=Hemoglobin alpha chain;
GN   Name=HBA1;
GN   and
GN   Name=HBA2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA1).
RX   PubMed=7448866; DOI=10.1016/0092-8674(80)90347-5;
RA   Michelson A.M., Orkin S.H.;
RT   "The 3' untranslated regions of the duplicated human alpha-globin genes are
RT   unexpectedly divergent.";
RL   Cell 22:371-377(1980).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA2).
RX   PubMed=6244294;
RA   Wilson J.T., Wilson L.B., Reddy V.B., Cavallesco C., Ghosh P.K.,
RA   Deriel J.K., Forget B.G., Weissman S.M.;
RT   "Nucleotide sequence of the coding portion of human alpha globin messenger
RT   RNA.";
RL   J. Biol. Chem. 255:2807-2815(1980).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2).
RX   PubMed=6452630; DOI=10.1073/pnas.77.12.7054;
RA   Liebhaber S.A., Goossens M.J., Kan Y.W.;
RT   "Cloning and complete nucleotide sequence of human 5'-alpha-globin gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:7054-7058(1980).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6946451; DOI=10.1073/pnas.78.8.5041;
RA   Orkin S.H., Goff S.C., Hechtman R.L.;
RT   "Mutation in an intervening sequence splice junction in man.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:5041-5045(1981).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-32.
RX   PubMed=11410421;
RA   Zhao Y., Xu X.;
RT   "Alpha2(CD31 AGG-->AAG, Arg-->Lys) causing non-deletional alpha-thalassemia
RT   in a Chinese family with HbH disease.";
RL   Haematologica 86:541-542(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA1).
RX   PubMed=11402454;
RA   Zhao Y., Zhong M., Liu Z., Xu X.;
RT   "Rapid detection of the common alpha-thalassemia-2 determinants by PCR
RT   assay.";
RL   Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:216-218(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALPHA-1 AND ALPHA-2).
RX   PubMed=16728641; DOI=10.1126/science.1126431;
RA   De Gobbi M., Viprakasit V., Hughes J.R., Fisher C., Buckle V.J., Ayyub H.,
RA   Gibbons R.J., Vernimmen D., Yoshinaga Y., de Jong P., Cheng J.-F.,
RA   Rubin E.M., Wood W.G., Bowden D., Higgs D.R.;
RT   "A regulatory SNP causes a human genetic disease by creating a new
RT   transcriptional promoter.";
RL   Science 312:1215-1217(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA2).
RC   TISSUE=Blood;
RA   Kutlar F., Leithner C., Kutlar A.;
RT   "Rapid sequencing of mRNA of the human alpha two globin, directly isolated
RT   from reticulocytes in whole blood.";
RL   Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (HBA1).
RC   TISSUE=Blood;
RA   Kutlar F., Leithner C., Kutlar A.;
RT   "cDNA sequencing of human alpha one globin mRNA, the 3'untranslated region
RT   is different than alpha two globin.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RA   Kutlar F., Holley L., Leithner C., Kutlar A.;
RT   "An alpha chain variant 'Hemoglobin J-Toronto (Cd.5 /Ala to Asp)' mutation
RT   was detected on the alpha-1 globin mRNA by sequencing of cDNA.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2), AND VARIANT EVANS MET-63.
RC   TISSUE=Blood;
RA   Kutlar F., Elam D., Hoff J.V., Holley L., Kutlar A.;
RT   "Unstable Hb 'Evans' (GTG->ATG/Val 62 Met) was detected on the alpha-2
RT   globin gene of an Hispanic girl.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (HBA2), AND VARIANT G-PHILADELPHIA
RP   LYS-69.
RA   Kutlar F., Davis D.H., Nechtman J., Elam D.;
RT   "Hb G-Philadelphia (Alpha,Codon 68;AAC>AAG/Asn>Lys)in black is detected on
RT   a chromosome that carries alpha 3.7 kb deletion showed completely normal
RT   alpha-2 globin gene sequence.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HBA1 AND HBA2).
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., Tufarelli C.,
RA   Kearney L., Buckle V.J., Doggett N.A., Flint J., Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2 Mb of
RT   the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (HBA1 AND HBA2).
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (HBA1 AND HBA2).
RC   TISSUE=Bone marrow, Brain, Lung, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=13872627; DOI=10.1515/bchm2.1961.325.1.283;
RA   Braunitzer G., Gehring-Muller R., Hilschmann N., Hilse K., Hobom G.,
RA   Rudloff V., Wittmann-Liebold B.;
RT   "The constitution of normal adult human haemoglobin.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 325:283-286(1961).
RN   [18]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=13954546;
RA   Hill R.J., Konigsberg W.;
RT   "The structure of human hemoglobin: IV. The chymotryptic digestion of the
RT   alpha chain of human hemoglobin.";
RL   J. Biol. Chem. 237:3151-3156(1962).
RN   [19]
RP   PROTEIN SEQUENCE OF 2-142.
RX   PubMed=14093912; DOI=10.1021/bi00906a030;
RA   Schroeder W.A., Shelton J.R., Shelton J.B., Cormick J.;
RT   "The amino acid sequence of the alpha chain of human fetal hemoglobin.";
RL   Biochemistry 2:1353-1357(1963).
RN   [20]
RP   PROTEIN SEQUENCE OF 2-32.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [21]
RP   PROTEIN SEQUENCE OF 128-142, AND VARIANT ETHIOPIA HIS-141.
RC   TISSUE=Umbilical cord blood;
RX   PubMed=1428951; DOI=10.3109/03630269209005699;
RA   Webber B.B., Wilson J.B., Gu L.-H., Huisman T.H.J.;
RT   "Hb Ethiopia or alpha 2(140)(HC2)Tyr----His beta 2.";
RL   Hemoglobin 16:441-443(1992).
RN   [22]
RP   GLYCATION AT LYS-8; LYS-17; LYS-41 AND LYS-62, AND LACK OF GLYCATION AT
RP   LYS-12; LYS-57; LYS-61; LYS-91 AND LYS-100.
RX   PubMed=7358733;
RA   Shapiro R., McManus M.J., Zalut C., Bunn H.F.;
RT   "Sites of nonenzymatic glycosylation of human hemoglobin A.";
RL   J. Biol. Chem. 255:3120-3127(1980).
RN   [23]
RP   PROTEOLYTIC CLEAVAGE (MICROBIAL INFECTION) BY N.AMERICANUS APR-2, AND
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=12552433; DOI=10.1086/367708;
RA   Williamson A.L., Brindley P.J., Abbenante G., Datu B.J., Prociv P.,
RA   Berry C., Girdwood K., Pritchard D.I., Fairlie D.P., Hotez P.J., Zhan B.,
RA   Loukas A.;
RT   "Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum
RT   proteins in a host-specific fashion.";
RL   J. Infect. Dis. 187:484-494(2003).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; THR-9; TYR-25; SER-36 AND
RP   SER-50, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF DEOXYHEMOGLOBIN.
RX   PubMed=1177322; DOI=10.1016/s0022-2836(75)80037-4;
RA   Fermi G.;
RT   "Three-dimensional Fourier synthesis of human deoxyhaemoglobin at 2.5-A
RT   resolution: refinement of the atomic model.";
RL   J. Mol. Biol. 97:237-256(1975).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=7373648; DOI=10.1016/0022-2836(80)90308-3;
RA   Baldwin J.M.;
RT   "The structure of human carbonmonoxy haemoglobin at 2.7-A resolution.";
RL   J. Mol. Biol. 136:103-128(1980).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF LIGANDED R2 STATE.
RX   PubMed=1512262;
RA   Silva M.M., Rogers P.H., Arnone A.;
RT   "A third quaternary structure of human hemoglobin A at 1.7-A resolution.";
RL   J. Biol. Chem. 267:17248-17256(1992).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF HB GOWER-2.
RX   PubMed=9665850; DOI=10.1006/jmbi.1998.1868;
RA   Sutherland-Smith A.J., Baker H.M., Hofmann O.M., Brittain T., Baker E.N.;
RT   "Crystal structure of a human embryonic haemoglobin: the carbonmonoxy form
RT   of Gower II (alpha2 epsilon2) haemoglobin at 2.9-A resolution.";
RL   J. Mol. Biol. 280:475-484(1998).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF VARIANT HB CATONSVILLE GLU-38 INS.
RX   PubMed=8448109; DOI=10.1021/bi00061a007;
RA   Kavanaugh J.S., Moo-Penn W.F., Arnone A.;
RT   "Accommodation of insertions in helices: the mutation in hemoglobin
RT   Catonsville (Pro 37 alpha-Glu-Thr 38 alpha) generates a 3(10)-->alpha
RT   bulge.";
RL   Biochemistry 32:2509-2513(1993).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (3.60 ANGSTROMS), AND INTERACTION WITH STAPHYLOCOCCUS
RP   AUREUS PROTEIN ISDB.
RX   PubMed=29109153; DOI=10.1074/jbc.m117.806562;
RA   Bowden C.F.M., Chan A.C.K., Li E.J.W., Arrieta A.L., Eltis L.D.,
RA   Murphy M.E.P.;
RT   "Structure-function analyses reveal key features in Staphylococcus aureus
RT   IsdB-associated unfolding of the heme-binding pocket of human hemoglobin.";
RL   J. Biol. Chem. 293:177-190(2018).
RN   [34]
RP   VARIANT J-CAPE TOWN GLN-93.
RX   PubMed=5988206; DOI=10.1038/212792a0;
RA   Botha M.C., Beale D., Isaacs W.A., Lehmann H.;
RT   "Hemoglobin J Cape Town-alpha-2 92 arginine replaced by glutamine beta-2.";
RL   Nature 212:792-795(1966).
RN   [35]
RP   VARIANT BIBBA PRO-137.
RX   PubMed=5440849;
RA   Smith L.L., Barton B.P., Huisman T.H.;
RT   "Subunit dissociation of the unstable hemoglobin Bibba (alpha 2-
RT   136Pro(H19)beta 2).";
RL   J. Biol. Chem. 245:2185-2188(1970).
RN   [36]
RP   CHARACTERIZATION OF VARIANT J-CAPE TOWN GLN-93.
RX   PubMed=5091982; DOI=10.1016/0022-2836(71)90029-5;
RA   Nagel R.L., Gibson Q.H., Jenkins T.;
RT   "Ligand binding in hemoglobin J Capetown.";
RL   J. Mol. Biol. 58:643-650(1971).
RN   [37]
RP   VARIANT HOPKINS-II ASP-113.
RX   PubMed=5288820; DOI=10.1038/newbio234248a0;
RA   Charache S., Ostertag W., von Ehrenstein G.;
RT   "Clinical studies and physiological properties of Hopkins-2 haemoglobin.";
RL   Nature New Biol. 234:248-251(1971).
RN   [38]
RP   VARIANT DENMARK HILL ALA-96.
RX   PubMed=5085669; DOI=10.1016/0005-2795(72)90006-2;
RA   Wiltshire B.G., Clark K.G., Lorkin P.A., Lehmann H.;
RT   "Haemoglobin Denmark Hill 95 (G2) Pro-Ala, a variant with unusual
RT   electrophoretic and oxygen-binding properties.";
RL   Biochim. Biophys. Acta 278:459-464(1972).
RN   [39]
RP   VARIANT SETIF TYR-95.
RX   PubMed=4667378; DOI=10.1016/0014-5793(72)80645-8;
RA   Wajcman H., Belkhodja O., Labie D.;
RT   "Hb Setif: G1 (94) Asp-Tyr. A new chain hemoglobin variant with
RT   substitution of the residue involved in hydrogen bond between unlike
RT   subunits.";
RL   FEBS Lett. 27:298-300(1972).
RN   [40]
RP   VARIANT ANN ARBOR ARG-81.
RX   PubMed=5033650; DOI=10.1126/science.176.4042.1427;
RA   Adams J.G. III, Winter W.P., Rucknagel D.L., Spencer H.H.;
RT   "Biosynthesis of hemoglobin Ann Arbor: evidence for catabolic and feedback
RT   regulation.";
RL   Science 176:1427-1429(1972).
RN   [41]
RP   VARIANT SAWARA ALA-7.
RX   PubMed=4744335; DOI=10.1016/0005-2795(73)90169-4;
RA   Sumida I., Ohta Y., Imamura T., Yanase T.;
RT   "Hemoglobin Sawara: alpha 6(A4) aspartic acid leads to alanine.";
RL   Biochim. Biophys. Acta 322:23-26(1973).
RN   [42]
RP   VARIANT M-BOSTON/M-OSAKA TYR-59.
RX   PubMed=4521212; DOI=10.1073/pnas.70.12.3870;
RA   Pulsinelli P.D., Perutz M.F., Nagel R.L.;
RT   "Structure of hemoglobin M Boston, a variant with a five-coordinated ferric
RT   heme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 70:3870-3874(1973).
RN   [43]
RP   VARIANT J-ROVIGO ASP-54.
RX   PubMed=4824923; DOI=10.1016/0005-2795(74)90099-3;
RA   Alberti R., Mariuzzi G.M., Artibani L., Bruni E., Tentori L.;
RT   "A new haemoglobin variant: J-Rovigo alpha 53 (E-2) alanine leads to
RT   aspartic acid.";
RL   Biochim. Biophys. Acta 342:1-4(1974).
RN   [44]
RP   VARIANT HIROSAKI LEU-44.
RX   PubMed=1182166; DOI=10.1016/0005-2795(75)90325-6;
RA   Ohba Y., Miyaji T., Matsuoka M., Yokoyama M., Numakura H.;
RT   "Hemoglobin Hirosaki (alpha 43 [CE 1] Phe replaced by Leu), a new unstable
RT   variant.";
RL   Biochim. Biophys. Acta 405:155-160(1975).
RN   [45]
RP   VARIANT PONTOISE ASP-64.
RX   PubMed=849454; DOI=10.1016/0005-2795(77)90036-8;
RA   Thillet J., Blouquit Y., Perrone F., Rosa J.;
RT   "Hemoglobin Pontoise alpha63 Ala replaced by Asp(E12). A new fast moving
RT   variant.";
RL   Biochim. Biophys. Acta 491:16-22(1977).
RN   [46]
RP   CHARACTERIZATION OF VARIANT SAWARA ALA-7.
RX   PubMed=20980; DOI=10.1016/0005-2795(77)90253-7;
RA   Sasaki J., Imamura T., Sumida I., Yanase T., Ohya M.;
RT   "Increased oxygen affinity for hemoglobin Sawara: alphaA4(6) aspartic acid
RT   replaced by alanine.";
RL   Biochim. Biophys. Acta 495:183-186(1977).
RN   [47]
RP   VARIANT PORT PHILLIP PRO-92.
RX   PubMed=902765; DOI=10.1016/0014-5793(77)80940-x;
RA   Brennan S.O., Tauro G.P., Melrose W.;
RT   "Haemoglobin Port Phillip alpha91 (FG3) Leu replaced by Pro, a new unstable
RT   haemoglobin.";
RL   FEBS Lett. 81:115-117(1977).
RN   [48]
RP   VARIANT MOABIT ARG-87.
RX   PubMed=108887; DOI=10.1159/000207643;
RA   Knuth A., Pribilla W., Marti H.R., Winterhalter K.H.;
RT   "Hemoglobin Moabit: alpha 86 (F7) Leu leads to Arg: a new unstable abnormal
RT   hemoglobin.";
RL   Acta Haematol. 61:121-124(1979).
RN   [49]
RP   VARIANT PRATO SER-32.
RX   PubMed=486536; DOI=10.1016/0005-2795(79)90184-3;
RA   Marinucci M., Mavilio F., Massa A., Gabbianelli M., Fontanarosa P.P.,
RA   Camagna A., Ignesti C., Tentori L.;
RT   "A new abnormal human hemoglobin: Hb Prato (alpha 2 31 (B12) Arg leads to
RT   Ser beta 2).";
RL   Biochim. Biophys. Acta 578:534-540(1979).
RN   [50]
RP   VARIANT DUNN ASN-7.
RX   PubMed=478975; DOI=10.3109/03630267908998909;
RA   Jue D.L., Johnson M.H., Patchen L.C., Moo-Penn W.F.;
RT   "Hemoglobin Dunn: alpha 6 (A4) aspartic acid replaced by asparagine.";
RL   Hemoglobin 3:137-143(1979).
RN   [51]
RP   CHARACTERIZATION OF VARIANT DUNN ASN-7.
RX   PubMed=7435503; DOI=10.1002/ajh.2830090203;
RA   Charache S., Brimhall B., Zaatari G.;
RT   "Oxygen affinity and stability of hemoglobin Dunn alpha 6(A4)Asp replaced
RT   by Asn): use of isoelectric focusing in recognition of a new abnormal
RT   hemoglobin.";
RL   Am. J. Hematol. 9:151-160(1980).
RN   [52]
RP   VARIANT MILLEDGEVILLE LEU-45.
RX   PubMed=7213661; DOI=10.1016/0005-2795(80)90138-5;
RA   Honig G.R., Vida L.N., Shamsuddin M., Mason R.G., Schlumpf H.W., Luke R.A.;
RT   "Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new variant
RT   with increased oxygen affinity.";
RL   Biochim. Biophys. Acta 626:424-431(1980).
RN   [53]
RP   VARIANT LEGNANO LEU-142.
RX   PubMed=7462179; DOI=10.1093/oxfordjournals.jbchem.a133091;
RA   Giuliani A., Maffi D., Cappabianca M.P., Tentori L.;
RT   "Hemoglobin Legnano (alpha 2 141 (HC3) Arg leads to Leu beta2) a new high
RT   oxygen affinity variant. Functional and structural studies.";
RL   J. Biochem. 88:1233-1237(1980).
RN   [54]
RP   VARIANT SURESNES HIS-142.
RX   PubMed=7410435;
RA   Poyart C., Bursaux E., Arnone A., Bonaventura J., Bonaventura C.;
RT   "Structural and functional studies of hemoglobin Suresnes (arg 141 alpha 2
RT   replaced by His beta 2). Consequences of disrupting an oxygen-linked anion-
RT   binding site.";
RL   J. Biol. Chem. 255:9465-9473(1980).
RN   [55]
RP   VARIANT FERNDOWN VAL-7.
RX   PubMed=7238857; DOI=10.1016/0014-5793(81)81047-2;
RA   Lee-Potter J.P., Deacon-Smith R.A., Lehmann H., Robb L.;
RT   "Haemoglobin Ferndown (alpha 6 [A4] aspartic acid replaced by valine).";
RL   FEBS Lett. 126:117-119(1981).
RN   [56]
RP   VARIANT TOTTORI VAL-60.
RX   PubMed=7275660; DOI=10.3109/03630268108991818;
RA   Nakatsuji T., Miwa S., Ohba Y., Miyaji T., Matsumoto N., Matsuoka I.;
RT   "Hemoglobin Tottori (alpha 59[E8] glycine replaced by valine).";
RL   Hemoglobin 5:427-439(1981).
RN   [57]
RP   VARIANT KAWACHI ARG-45.
RX   PubMed=7068434; DOI=10.3109/03630268208996932;
RA   Harano T., Harano K., Ueda S., Shibata S., Imai K., Ohba Y., Shinohara T.,
RA   Horio S., Nishioka K., Shirotani H.;
RT   "Hemoglobin Kawachi [alpha 44 (CE2) Pro leads to Arg]: a new hemoglobin
RT   variant of high oxygen affinity with amino acid substitution at alpha 1
RT   beta 2 contact.";
RL   Hemoglobin 6:43-49(1982).
RN   [58]
RP   VARIANT KOKURA GLY-48.
RX   PubMed=7068437; DOI=10.3109/03630268208996936;
RA   Ohba Y., Hattori Y., Matsuoka M., Miyaji T., Fuyuno K.;
RT   "HB Kokura [alpha 47 (CE 5) Asp leads to Gly]: a slightly unstable
RT   variant.";
RL   Hemoglobin 6:69-74(1982).
RN   [59]
RP   VARIANT EVANSTON ARG-15.
RX   PubMed=6882779; DOI=10.1016/0167-4838(83)90122-x;
RA   Moo-Penn W.F., Baine R.M., Jue D.L., Johnson M.H., McGuffey J.E.,
RA   Benson J.M.;
RT   "Hemoglobin Evanston: alpha 14(A12) Trp leads to Arg. A variant hemoglobin
RT   associated with alpha-thalassemia-2.";
RL   Biochim. Biophys. Acta 747:65-70(1983).
RN   [60]
RP   VARIANT TOKONAME THR-140.
RX   PubMed=6188720; DOI=10.3109/03630268309038404;
RA   Harano T., Harano K., Shibata S., Ueda S., Imai K., Seki M.;
RT   "Hemoglobin Tokoname [alpha 139 (HC 1) Lys leads to Thr]: a new hemoglobin
RT   variant with a slightly increased oxygen affinity.";
RL   Hemoglobin 7:85-90(1983).
RN   [61]
RP   VARIANT IWATA ARG-88.
RX   PubMed=6874376;
RA   Liu G.Y., Zhang G.X., Nie S.Y., Luo H.Y., Teng Y.Q., Liu S.P., Song M.,
RA   Son L., Chen S.S., Jia P.C., Liang C.C.;
RT   "A case of hemoglobin Iwata [alpha 87(F8)His leads to Arg] in China.";
RL   Hemoglobin 7:279-282(1983).
RN   [62]
RP   VARIANT ETOBICOKE ARG-85.
RX   PubMed=6874377; DOI=10.3109/03630268309048660;
RA   Headlee M.G., Nakatsuji T., Lam H., Wrightstone R.N., Huisman T.H.;
RT   "Hb Etobicoke, alpha 85(F5) Ser leads to Arg found in a newborn of French-
RT   Indian-English descent.";
RL   Hemoglobin 7:285-287(1983).
RN   [63]
RP   VARIANT AICHI ARG-51.
RX   PubMed=6714429; DOI=10.1016/0014-5793(84)80337-3;
RA   Harano T., Harano K., Shibata S., Ueda S., Mori H., Seki M.;
RT   "Hemoglobin Aichi [alpha 50(CE8) His----Arg]: a new slightly unstable
RT   hemoglobin variant discovered in Japan.";
RL   FEBS Lett. 169:297-299(1984).
RN   [64]
RP   VARIANT CORDELE ALA-48.
RX   PubMed=6547117; DOI=10.3109/03630268408996959;
RA   Nakatsuji T., Wilson J.B., Huisman T.H.;
RT   "Hb Cordele alpha(2)47 (CE5)Asp----Ala beta 2. A mildly unstable variant
RT   observed in black twins.";
RL   Hemoglobin 8:37-46(1984).
RN   [65]
RP   VARIANT MANITOBA ARG-103, AND VARIANT CONTALDO ARG-104.
RX   PubMed=6547932; DOI=10.3109/03630268408991710;
RA   Sciarratta G.V., Ivaldi G., Molaro G.L., Sansone G., Salkie M.L.,
RA   Wilson J.B., Reese A.L., Huisman T.H.;
RT   "The characterization of hemoglobin Manitoba or alpha (2)102(G9)Ser----Arg
RT   beta 2 and hemoglobin Contaldo or alpha (2)103(G10)His----Arg beta 2 by
RT   high performance liquid chromatography.";
RL   Hemoglobin 8:169-181(1984).
RN   [66]
RP   CHARACTERIZATION OF VARIANT EVANSTON ARG-15.
RX   PubMed=6725558; DOI=10.1172/jci111382;
RA   Honig G.R., Shamsuddin M., Vida L.N., Mompoint M., Valcourt E., Bowie L.J.,
RA   Jones E.C., Powers P.A., Spritz R.A., Guis M.;
RT   "Hemoglobin Evanston (alpha 14 Trp----Arg). An unstable alpha-chain variant
RT   expressed as alpha-thalassemia.";
RL   J. Clin. Invest. 73:1740-1749(1984).
RN   [67]
RP   VARIANT NUNOBIKI CYS-142.
RX   PubMed=3973024; DOI=10.1172/jci111749;
RA   Shimasaki S.;
RT   "A new hemoglobin variant, hemoglobin Nunobiki [alpha 141 (HC3) Arg----
RT   Cys]. Notable influence of the carboxy-terminal cysteine upon various
RT   physico-chemical characteristics of hemoglobin.";
RL   J. Clin. Invest. 75:695-701(1985).
RN   [68]
RP   VARIANT LOIRE SER-89.
RX   PubMed=3142772; DOI=10.1111/j.1432-1033.1988.tb14377.x;
RA   Baklouti F., Baudin-Chich V., Kister J., Marden M., Teyssier G., Poyart C.,
RA   Delaunay J., Wajcman H.;
RT   "Increased oxygen affinity with normal heterotropic effects in hemoglobin
RT   Loire [alpha 88(F9)Ala----Ser].";
RL   Eur. J. Biochem. 177:307-312(1988).
RN   [69]
RP   VARIANT LUXEMBOURG HIS-25.
RX   PubMed=2599879; DOI=10.3109/03630268908998082;
RA   Groff P., Galacteros F., Kalmes G., Blouquit Y., Wajcman H.;
RT   "Hb Luxembourg [alpha 24(B5) Tyr----His]: a new unstable variant.";
RL   Hemoglobin 13:429-436(1989).
RN   [70]
RP   VARIANT MIYANO SER-42.
RX   PubMed=2634665; DOI=10.3109/03630268908998841;
RA   Ohba Y., Imai K., Uenaka R., Ami M., Fujisawa K., Itoh K., Hirakawa K.,
RA   Miyaji T.;
RT   "Hb Miyano or alpha 41(C6)Thr----Ser: a new high oxygen affinity alpha
RT   chain variant found in an erythremic blood donor.";
RL   Hemoglobin 13:637-647(1989).
RN   [71]
RP   VARIANT REIMS GLY-24.
RX   PubMed=2634669; DOI=10.3109/03630268908998846;
RA   Bardakdjian-Michau J., Rosa J., Galacteros F., Lancelot M., Marquart F.X.;
RT   "Hb Reims [alpha 2(23)(B4)Glu----Gly beta 2]: a new alpha chain variant
RT   with slightly decreased stability.";
RL   Hemoglobin 13:733-735(1989).
RN   [72]
RP   VARIANT ATTLEBORO PRO-139.
RX   PubMed=2108715; DOI=10.1021/bi00453a023;
RA   McDonald M.J., Michalski L.A., Turci S.M., Guillette R.A., Jue D.L.,
RA   Johnson M.H., Moo-Penn W.F.;
RT   "Structural, functional, and subunit assembly properties of hemoglobin
RT   Attleboro [alpha 138 (H21) Ser----Pro], a variant possessing a site
RT   maturation at a critical C-terminal residue.";
RL   Biochemistry 29:173-178(1990).
RN   [73]
RP   VARIANT FUKUTOMI VAL-127.
RX   PubMed=2079432; DOI=10.3109/03630269009005803;
RA   Hidaka K., Iuchi I., Kobayashi T., Katoh K., Yaguchi K.;
RT   "Hb Fukutomi [alpha 126(H9)Asp----Val]: a new hemoglobin variant with high
RT   oxygen affinity.";
RL   Hemoglobin 14:499-509(1990).
RN   [74]
RP   VARIANT DALLAS LYS-98.
RX   PubMed=1390940; DOI=10.1016/0925-4439(92)90021-e;
RA   Lendaro E., Ippoliti R., Brancaccio A., Bellelli A., Vallone B., Ivaldi G.,
RA   Sciarratta G.V., Castello C., Tomova S., Brunori M.;
RT   "Hemoglobin Dallas (alpha 97(G4)Asn-->Lys): functional characterization of
RT   a high oxygen affinity natural mutant.";
RL   Biochim. Biophys. Acta 1180:15-20(1992).
RN   [75]
RP   VARIANT ROUEN/ETHIOPIA HIS-141.
RX   PubMed=1390944; DOI=10.1016/0925-4439(92)90026-j;
RA   Wajcman H., Kister J., Marden M., Lahary A., Monconduit M., Galacteros F.;
RT   "Hemoglobin Rouen (alpha-140 (HC2) Tyr-->His): alteration of the alpha-
RT   chain C-terminal region and moderate increase in oxygen affinity.";
RL   Biochim. Biophys. Acta 1180:53-57(1992).
RN   [76]
RP   VARIANT AL-AIN ABU DHABI ASP-19.
RX   PubMed=1428941; DOI=10.3109/03630269209005687;
RA   Abbes S., M'Rad A., Fitzgerald P.A., Dormer P., Blouquit Y., Kister J.,
RA   Galacteros F., Wajcman H.;
RT   "HB Al-Ain Abu Dhabi [alpha 18(A16)Gly-->Asp]: a new hemoglobin variant
RT   discovered in an Emiratee family.";
RL   Hemoglobin 16:355-362(1992).
RN   [77]
RP   VARIANT QUESTEMBERT PRO-132.
RX   PubMed=8493987; DOI=10.1002/ajh.2830420407;
RA   Wajcman H., Vasseur C., Blouquit Y., Rosa J., Labie D., Najman A.,
RA   Reman O., Leporrier M., Galacteros F.;
RT   "Unstable alpha-chain hemoglobin variants with factitious beta-thalassemia
RT   biosynthetic ratio: Hb Questembert (alpha 131[H14]Ser-->Pro) and Hb Caen
RT   (alpha 132[H15]Val-->Gly).";
RL   Am. J. Hematol. 42:367-374(1993).
RN   [78]
RP   VARIANT ADANA ASP-60.
RX   PubMed=8237999; DOI=10.1002/ajh.2830440410;
RA   Cueruek M.A., Dimovski A.J., Baysal E., Gu L.H., Kutlar F.,
RA   Molchanova T.P., Webber B.B., Altay C., Guergey A., Huisman T.H.;
RT   "Hb Adana or alpha 2(59)(E8)Gly-->Asp beta 2, a severely unstable alpha 1-
RT   globin variant, observed in combination with the -(alpha)20.5 Kb alpha-
RT   thal-1 deletion in two Turkish patients.";
RL   Am. J. Hematol. 44:270-275(1993).
RN   [79]
RP   VARIANT MONTEFIORE TYR-127.
RX   PubMed=8798486; DOI=10.1074/jbc.271.38.22990;
RA   Wajcman H., Kister J., Galacteros F., Spielvogel A., Lin M.J.,
RA   Vidugiris G.J., Hirsch R.E., Friedman J.M., Nagel R.L.;
RT   "Hb Montefiore (126(H9)Asp-->Tyr). High oxygen affinity and loss of
RT   cooperativity secondary to C-terminal disruption.";
RL   J. Biol. Chem. 271:22990-22998(1996).
RN   [80]
RP   VARIANT ATAGO TYR-86.
RX   PubMed=5115619;
RA   Fujiwara N., Maekawa T., Matsuda G.;
RT   "Hemoglobin Atago (alpha2-85 Tyr beta-2) a new abnormal human hemoglobin
RT   found in Nagasaki. Biochemical studies on hemoglobins and myoglobins. VI.";
RL   Int. J. Protein Res. 3:35-39(1971).
RN   [81]
RP   VARIANT AUCKLAND ASN-88.
RX   PubMed=9322075; DOI=10.3109/03630269708993126;
RA   Brennan S.O., Matthews J.R.;
RT   "Hb Auckland [alpha 87(F8) His-->Asn]: a new mutation of the proximal
RT   histidine identified by electrospray mass spectrometry.";
RL   Hemoglobin 21:393-403(1997).
RN   [82]
RP   VARIANTS J-BUDA ASN-62 AND G-PEST ASN-75.
RA   Brimhall B.J., Duerst M., Hollan S.R., Stenzel P., Szelenyi J., Jones R.T.;
RT   "Structural characterizations of hemoglobins J-Buda (alpha 61 (E10) Lys-to-
RT   Asn) and G-Pest (alpha 74 (EF3) Asp-to-Asn).";
RL   Biochim. Biophys. Acta 336:344-360(1974).
RN   [83]
RP   VARIANT CEMENELUM TRP-93.
RX   PubMed=8148419; DOI=10.1007/bf01715134;
RA   Wajcman H., Kister J., M'Rad A., Soummer A.M., Galacteros F.;
RT   "Hb Cemenelum [alpha 92 (FG4) Arg-->Trp]: a hemoglobin variant of the alpha
RT   1/beta 2 interface that displays a moderate increase in oxygen affinity.";
RL   Ann. Hematol. 68:73-76(1994).
RN   [84]
RP   VARIANTS CHONGQING ARG-3 AND HARBIN MET-17.
RX   PubMed=6526652; DOI=10.3109/03630268408991742;
RA   Zeng Y.-T., Huang S.-Z., Qiu X.-K., Cheng G.-C., Ren Z.-R., Jin Q.-C.,
RA   Chen C.-Y., Jiao C.-T., Tang Z.-G., Liu R.-H., Bao X.-H., Zeng L.-Z.,
RA   Duan Y.-Q., Zhang G.-Y.;
RT   "Hemoglobin Chongqing [alpha 2(NA2)Leu-->Arg] and hemoglobin Harbin [alpha
RT   16(A14)Lys-->Met] found in China.";
RL   Hemoglobin 8:569-581(1984).
RN   [85]
RP   VARIANT CLINIC LYS-61 DEL.
RX   PubMed=10206681;
RX   DOI=10.1002/(sici)1098-1004(1998)11:5<412::aid-humu14>3.0.co;2-r;
RA   Ayala S., Colomer D., Gelpi J.L., Corron J.L.V.;
RT   "Alpha-thalassaemia due to a single codon deletion in the alpha 1-globin
RT   gene. Computational structural analysis of the new alpha-chain variant.";
RL   Hum. Mutat. 11:412-412(1998).
RN   [86]
RP   VARIANT DAVENPORT HIS-79.
RX   PubMed=2101836; DOI=10.3109/03630269009046968;
RA   Wilson J.B., Webber B.B., Plaseska D., de Alarcon P.A., McMillan S.K.,
RA   Huisman T.H.J.;
RT   "Hb Davenport or alpha 2(78)(EF7)Asn-->His beta 2.";
RL   Hemoglobin 14:599-605(1990).
RN   [87]
RP   VARIANT EVANS MET-63.
RX   PubMed=2606724; DOI=10.3109/03630268908993106;
RA   Wilson J.B., Webber B.B., Kutlar A., Reese A.L., McKie V.C., Lutcher C.L.,
RA   Felice A.E., Huisman T.H.J.;
RT   "Hb Evans or alpha 262(E11)Val-->Met beta 2; an unstable hemoglobin causing
RT   a mild hemolytic anemia.";
RL   Hemoglobin 13:557-566(1989).
RN   [88]
RP   VARIANTS SPANISH TOWN VAL-28 AND FORT DE FRANCE ARG-46.
RX   PubMed=2752146;
RA   Cash F.E., Monplaisir N., Goossens M., Liebhaber S.A.;
RT   "Locus assignment of two alpha-globin structural mutants from the Caribbean
RT   basin: alpha Fort de France (alpha 45 Arg) and alpha Spanish Town (alpha 27
RT   Val).";
RL   Blood 74:833-835(1989).
RN   [89]
RP   VARIANT GODAVARI THR-96.
RX   PubMed=9494044; DOI=10.3109/03630269809071513;
RA   Wajcman H., Kister J., Riou J., Galacteros F., Girot R.,
RA   Maier-Redelsperger M., Nayudu N.V.S., Giordano P.C.;
RT   "Hb Godavari [alpha 95(G2)Pro-->Thr]: a neutral amino acid substitution in
RT   the alpha 1 beta 2 interface that modifies the electrophoretic mobility of
RT   hemoglobin.";
RL   Hemoglobin 22:11-22(1998).
RN   [90]
RP   VARIANT GRADY GLU-PHE-THR-119 INS.
RX   PubMed=4528583; DOI=10.1073/pnas.71.8.3270;
RA   Huisman T.H.J., Wilson J.B., Gravely M., Hubbard M.;
RT   "Hemoglobin Grady: the first example of a variant with elongated chains due
RT   to an insertion of residues.";
RL   Proc. Natl. Acad. Sci. U.S.A. 71:3270-3273(1974).
RN   [91]
RP   VARIANT HANAMAKI GLU-140.
RX   PubMed=1634363; DOI=10.3109/03630269209005677;
RA   Orisaka M., Tajima T., Harano T., Harano K., Kushida Y., Imai K.;
RT   "A new alpha chain variant, Hb Hanamaki or alpha 2(139)(HC1)Lys-->Glu beta
RT   2, found in a Japanese family.";
RL   Hemoglobin 16:67-71(1992).
RN   [92]
RP   VARIANT HANDA MET-91.
RX   PubMed=6815131; DOI=10.3109/03630268208996943;
RA   Harano T., Harano K., Shibata S., Ueda S., Imai K., Seki M.;
RT   "HB Handa [alpha 90 (FG 2) Lys replaced by Met]: structure and biosynthesis
RT   of a new slightly higher oxygen affinity variant.";
RL   Hemoglobin 6:379-389(1982).
RN   [93]
RP   VARIANT HASHARON HIS-48.
RX   PubMed=5780195; DOI=10.1172/jci106041;
RA   Charache S., Mondzac A.M., Gessner U.;
RT   "Hemoglobin Hasharon (alpha-2-47 his(CD5)beta-2): a hemoglobin found in low
RT   concentration.";
RL   J. Clin. Invest. 48:834-847(1969).
RN   [94]
RP   VARIANT HOBART ARG-21.
RX   PubMed=3654264; DOI=10.3109/03630268709017887;
RA   Fleming P.J., Sumner D.R., Wyatt K., Hughes W.G., Melrose W.D.,
RA   Jupe D.M.D., Baikie M.J.;
RT   "Hemoglobin Hobart or alpha 20(Bl)His-->Arg: a new alpha chain hemoglobin
RT   variant.";
RL   Hemoglobin 11:211-220(1987).
RN   [95]
RP   VARIANT INKSTER VAL-86.
RX   PubMed=4212045; DOI=10.1111/j.1365-2141.1974.tb00489.x;
RA   Reed R.E., Winter W.P., Rucknagel D.L.;
RT   "Haemoglobin Inkster (alpha2 85aspartic acid leads to valine beta2)
RT   coexisting with beta-thalassaemia in a Caucasian family.";
RL   Br. J. Haematol. 26:475-484(1974).
RN   [96]
RP   VARIANT KANAGAWA MET-41.
RX   PubMed=1634355; DOI=10.3109/03630269209005670;
RA   Miyashita H., Hashimoto K., Mohri H., Ohokubo T., Harano T., Harano K.,
RA   Imai K.;
RT   "Hb Kanagawa [alpha 40(C5)Lys-->Met]: a new alpha chain variant with an
RT   increased oxygen affinity.";
RL   Hemoglobin 16:1-10(1992).
RN   [97]
RP   VARIANT KURDISTAN TYR-48.
RX   PubMed=8195005; DOI=10.3109/03630269409014141;
RA   Giordano P.C., Harteveld C.L., Streng H., Oosterwijk J.C.,
RA   Heister J.G.A.M., Amons R., Bernini L.F.;
RT   "Hb Kurdistan [alpha 47(CE5)Asp-->Tyr], a new alpha chain variant in
RT   combination with beta (0)-thalassemia.";
RL   Hemoglobin 18:11-18(1994).
RN   [98]
RP   VARIANT KUROSAKI GLU-8.
RX   PubMed=7558876; DOI=10.3109/03630269509036940;
RA   Harano T., Harano K., Imai K., Murakami T., Matsubara H.;
RT   "Hb Kurosaki [alpha 7(A5)Lys-->Glu]: a new alpha chain variant found in a
RT   Japanese woman.";
RL   Hemoglobin 19:197-201(1995).
RN   [99]
RP   VARIANT J-MEERUT/J-BIRMINGHAM GLU-121.
RX   PubMed=7713747; DOI=10.3109/03630269409045775;
RA   Yalcin A., Avcu F., Beyan C., Guergey A., Ural A.U.;
RT   "A case of HB J-Meerut (or Hb J-Birmingham) [alpha 120(H3)Ala-->Glu].";
RL   Hemoglobin 18:433-435(1994).
RN   [100]
RP   VARIANT MELUSINE SER-115.
RX   PubMed=8294199; DOI=10.3109/03630269308997494;
RA   Wacjman H., Klames G., Groff P., Prome D., Riou J., Galacteros F.;
RT   "Hb Melusine [alpha 114(GH2)Pro-->Ser]: a new neutral hemoglobin variant.";
RL   Hemoglobin 17:397-405(1993).
RN   [101]
RP   VARIANT MONTGOMERY ARG-49.
RX   PubMed=1115799;
RA   Brimhall B., Jones R.T., Schneider R.G., Hosty T.S., Tomlin G., Atkins R.;
RT   "Two new hemoglobins. Hemoglobin Alabama (beta39(C5)Gln leads to Lys) and
RT   hemoglobin Montgomery (alpha 48(CD 6) Leu leads to Arg).";
RL   Biochim. Biophys. Acta 379:28-32(1975).
RN   [102]
RP   VARIANT PETAH TIKVA ASP-111.
RX   PubMed=7470621;
RA   Honig G.R., Shamsuddin M., Zaizov R., Steinherz M., Solar I., Kirschman C.;
RT   "Hemoglobin Petah Tikva (alpha 110 Ala replaced by Asp): a new unstable
RT   variant with alpha-thalassemia-like expression.";
RL   Blood 57:705-711(1981).
RN   [103]
RP   VARIANT PHNOM PENH ILE-118 INS.
RX   PubMed=9452028; DOI=10.1002/humu.1380110107;
RA   Wajcman H., Prehu M.O., Prehu C., Blouquit Y., Prome D., Galacteros F.;
RT   "Hemoglobin Phnom Penh [alpha117Phe(H1)-Ile-alpha118Thr(H2)]; evidence for
RT   a hotspot for insertion of residues in the third exon of the alpha1-globin
RT   gene.";
RL   Hum. Mutat. Suppl. 1:S20-S22(1998).
RN   [104]
RP   VARIANT PORT HURON ARG-57.
RX   PubMed=1802882; DOI=10.3109/03630269108998858;
RA   Zwerdling T., Williams S., Nasr S.A., Rucknagel D.L.;
RT   "Hb Port Huron [alpha 56 (E5)Lys-->Arg]: a new alpha chain variant.";
RL   Hemoglobin 15:381-391(1991).
RN   [105]
RP   VARIANT SHENYANG GLU-27.
RX   PubMed=7161109;
RA   Zeng Y.-T., Huang S.-Z., Zhou X., Qiu X.-K., Dong Q., Li M., Bai J.;
RT   "Hb Shenyang (alpha 26 (B7) Ala replaced by Glu): a new unstable variant
RT   found in China.";
RL   Hemoglobin 6:625-628(1982).
RN   [106]
RP   VARIANT SUAN-DOK ARG-110.
RX   PubMed=478977; DOI=10.3109/03630267908998911;
RA   Sanguansermsri T., Matragoon S., Changloah L., Flatz G.;
RT   "Hemoglobin Suan-Dok (alpha 2 109 (G16) Leu replaced by Arg beta 2): an
RT   unstable variant associated with alpha-thalassemia.";
RL   Hemoglobin 3:161-174(1979).
RN   [107]
RP   INVOLVEMENT IN HEIBAN, AND VARIANT TOYAMA ARG-137.
RX   PubMed=2833478; DOI=10.3109/03630268709027870;
RA   Ohba Y., Yamamoto K., Hattori Y., Kawata R., Miyaji T.;
RT   "Hyperunstable hemoglobin Toyama [alpha 2 136(H19)Leu----Arg beta 2]:
RT   detection and identification by in vitro biosynthesis with radioactive
RT   amino acids.";
RL   Hemoglobin 11:539-556(1987).
RN   [108]
RP   VARIANT SUN PRAIRIE PRO-131.
RX   PubMed=2079430; DOI=10.3109/03630269009005801;
RA   Harkness M., Harkness D.R., Kutlar F., Kutlar A., Wilson J.B., Webber B.B.,
RA   Codrington J.F., Huisman T.H.J.;
RT   "Hb Sun Prairie or alpha(2)130(H13)Ala-->Pro beta 2, a new unstable variant
RT   occurring in low quantities.";
RL   Hemoglobin 14:479-489(1990).
RN   [109]
RP   VARIANT SWAN RIVER GLY-7.
RX   PubMed=8745434; DOI=10.3109/03630269609027912;
RA   Harano T., Harano K., Imai K., Terunuma S.;
RT   "HB Swan River [alpha 6(A4)Asp-->Gly] observed in a Japanese man.";
RL   Hemoglobin 20:75-78(1996).
RN   [110]
RP   VARIANT THIONVILLE GLU-2.
RX   PubMed=1618774;
RA   Vasseur C., Blouquit Y., Kister J., Prome D., Kavanaugh J.S., Rogers P.H.,
RA   Guillemin C., Arnone A., Galacteros F., Poyart C., Rosa J., Wajcman H.;
RT   "Hemoglobin Thionville. An alpha-chain variant with a substitution of a
RT   glutamate for valine at NA-1 and having an acetylated methionine NH2
RT   terminus.";
RL   J. Biol. Chem. 267:12682-12691(1992).
RN   [111]
RP   VARIANT TUNIS-BIZERTE PRO-130.
RX   PubMed=7786798; DOI=10.1111/j.1365-2141.1995.tb03382.x;
RA   Darbellay R., Mach-Pascual S., Rose K., Graf J., Beris P.;
RT   "Haemoglobin Tunis-Bizerte: a new alpha 1 globin 129 Leu-->Pro unstable
RT   variant with thalassaemic phenotype.";
RL   Br. J. Haematol. 90:71-76(1995).
RN   [112]
RP   VARIANT TURRIFF GLU-100.
RX   PubMed=1634357; DOI=10.3109/03630269209005671;
RA   Langdown J.V., Davidson R.J., Williamson D.;
RT   "A new alpha chain variant, Hb Turriff [alpha 99(G6)Lys-->Glu]: the
RT   interference of abnormal hemoglobins in Hb A1c determination.";
RL   Hemoglobin 16:11-17(1992).
RN   [113]
RP   VARIANT VAL DE MARNE ARG-134.
RX   PubMed=8294200; DOI=10.3109/03630269308997495;
RA   Wacjman H., Kister J., M'Rad A., Marden M.C., Riou J., Galacteros F.;
RT   "Hb Val de Marne [alpha 133(H16)Ser-->Arg]: a new hemoglobin variant with
RT   moderate increase in oxygen affinity.";
RL   Hemoglobin 17:407-417(1993).
RN   [114]
RP   VARIANT WESTMEAD GLN-123.
RX   PubMed=1686260; DOI=10.3109/03630269109027881;
RA   Jiang N.H., Liang S., Wen X.J., Liang R., Su C., Tang Z.;
RT   "Hb Westmead: an alpha 2-globin gene mutation detected by polymerase chain
RT   reaction and Stu I cleavage.";
RL   Hemoglobin 15:291-295(1991).
RN   [115]
RP   VARIANT WOODVILLE TYR-7.
RX   PubMed=3754246; DOI=10.3109/03630268609046440;
RA   Como P.F., Barber S., Sage R.E., Kronenberg H.;
RT   "Hemoglobin Woodville: alpha (2)6(A4) aspartic acid-->tyrosine.";
RL   Hemoglobin 10:135-141(1986).
RN   [116]
RP   VARIANT YUDA ASP-131.
RX   PubMed=1428950; DOI=10.3109/03630269209005698;
RA   Fujisawa K., Hattori Y., Ohba Y., Ando S.;
RT   "Hb Yuda or alpha 130(H13)Ala-->Asp; a new alpha chain variant with low
RT   oxygen affinity.";
RL   Hemoglobin 16:435-439(1992).
RN   [117]
RP   VARIANT ZAIRE HIS-LEU-PRO-ALA-GLU-117 INS.
RX   PubMed=1511986; DOI=10.1007/bf00221961;
RA   Wajcman H., Blouquit Y., Vasseur C., le Querrec A., Laniece M.,
RA   Melevendi C., Rasore A., Galacteros F.;
RT   "Two new human hemoglobin variants caused by unusual mutational events: Hb
RT   Zaire contains a five residue repetition within the alpha-chain and Hb
RT   Duino has two residues substituted in the beta-chain.";
RL   Hum. Genet. 89:676-680(1992).
RN   [118]
RP   VARIANT HBH VAL-63 DEL.
RX   PubMed=10569720; DOI=10.3109/03630269909090747;
RA   Traeger-Synodinos J., Harteveld C.L., Kanavakis E., Giordano P.C.,
RA   Kattamis C., Bernini L.F.;
RT   "Hb Aghia Sophia [alpha62(E11)Val-->0 (alpha1)], an 'in-frame' deletion
RT   causing alpha-thalassemia.";
RL   Hemoglobin 23:317-324(1999).
RN   [119]
RP   VARIANT BOGHE GLN-59, AND VARIANT CHAROLLES TYR-104.
RX   PubMed=10569723; DOI=10.3109/03630269909090750;
RA   Lacan P., Francina A., Souillet G., Aubry M., Couprie N., Dementhon L.,
RA   Becchi M.;
RT   "Two new alpha chain variants: Hb Boghe [alpha58(E7)His-->Gln, alpha2], a
RT   variant on the distal histidine, and Hb Charolles [alpha103(G10)His-Tyr,
RT   alpha1].";
RL   Hemoglobin 23:345-352(1999).
RN   [120]
RP   VARIANT CAMPINAS VAL-27, AND VARIANT WEST ONE GLY-127.
RX   PubMed=14576901; DOI=10.1590/s0100-879x2003001100004;
RA   Jorge S.B., Melo M.B., Costa F.F., Sonati M.F.;
RT   "Screening for mutations in human alpha-globin genes by nonradioactive
RT   single-strand conformation polymorphism.";
RL   Braz. J. Med. Biol. Res. 36:1471-1474(2003).
RN   [121]
RP   VARIANT BASSETT ALA-95, AND CHARACTERIZATION OF VARIANT BASSETT ALA-95.
RX   PubMed=15495251; DOI=10.1002/ajh.20184;
RA   Abdulmalik O., Safo M.K., Lerner N.B., Ochotorena J., Daikhin E., Lakka V.,
RA   Santacroce R., Abraham D.J., Asakura T.;
RT   "Characterization of hemoglobin Bassett (alpha94Asp-->Ala), a variant with
RT   very low oxygen affinity.";
RL   Am. J. Hematol. 77:268-276(2004).
RN   [122]
RP   VARIANT PLASENCIA ARG-126.
RX   PubMed=15921163; DOI=10.1081/hem-58578;
RA   Martin G., Villegas A., Gonzalez F.A., Ropero P., Hojas R., Polo M.,
RA   Mateo M., Salvador M., Benavente C.;
RT   "A novel mutation of the alpha2-globin causing alpha(+)-thalassemia: Hb
RT   Plasencia [alpha125(H8)Leu-->Arg (alpha2).";
RL   Hemoglobin 29:113-117(2005).
CC   -!- FUNCTION: Involved in oxygen transport from the lung to the various
CC       peripheral tissues.
CC   -!- SUBUNIT: Heterotetramer of two alpha chains and two beta chains in
CC       adult hemoglobin A (HbA); two alpha chains and two delta chains in
CC       adult hemoglobin A2 (HbA2); two alpha chains and two epsilon chains in
CC       early embryonic hemoglobin Gower-2; two alpha chains and two gamma
CC       chains in fetal hemoglobin F (HbF).
CC   -!- SUBUNIT: (Microbial infection) Interacts with Staphylococcus aureus
CC       protein isdB. {ECO:0000269|PubMed:29109153}.
CC   -!- INTERACTION:
CC       P69905; Q9NZD4: AHSP; NbExp=2; IntAct=EBI-714680, EBI-720250;
CC       P69905; Q2TAC2: CCDC57; NbExp=3; IntAct=EBI-714680, EBI-2808286;
CC       P69905; P00387: CYB5R3; NbExp=2; IntAct=EBI-714680, EBI-1046040;
CC       P69905; P68871: HBB; NbExp=27; IntAct=EBI-714680, EBI-715554;
CC       P69905; P02042: HBD; NbExp=3; IntAct=EBI-714680, EBI-6152722;
CC       P69905; P02100: HBE1; NbExp=4; IntAct=EBI-714680, EBI-6190240;
CC       P69905; P69892: HBG2; NbExp=3; IntAct=EBI-714680, EBI-3910089;
CC       P69905; P09105: HBQ1; NbExp=3; IntAct=EBI-714680, EBI-10193656;
CC       P69905; Q15323: KRT31; NbExp=3; IntAct=EBI-714680, EBI-948001;
CC       P69905; O76011: KRT34; NbExp=3; IntAct=EBI-714680, EBI-1047093;
CC       P69905; Q6A162: KRT40; NbExp=3; IntAct=EBI-714680, EBI-10171697;
CC       P69905; P29474: NOS3; NbExp=2; IntAct=EBI-714680, EBI-1391623;
CC       P69905; P0DPK4: NOTCH2NLC; NbExp=3; IntAct=EBI-714680, EBI-22310682;
CC       P69905; P0DMV8; NbExp=3; IntAct=EBI-714680, EBI-11820565;
CC   -!- TISSUE SPECIFICITY: Red blood cells.
CC   -!- PTM: The initiator Met is not cleaved in variant Thionville and is
CC       acetylated.
CC   -!- DISEASE: Heinz body anemias (HEIBAN) [MIM:140700]: Form of non-
CC       spherocytic hemolytic anemia of Dacie type 1. After splenectomy, which
CC       has little benefit, basophilic inclusions called Heinz bodies are
CC       demonstrable in the erythrocytes. Before splenectomy, diffuse or
CC       punctate basophilia may be evident. Most of these cases are probably
CC       instances of hemoglobinopathy. The hemoglobin demonstrates heat
CC       lability. Heinz bodies are observed also with the Ivemark syndrome
CC       (asplenia with cardiovascular anomalies) and with glutathione
CC       peroxidase deficiency. {ECO:0000269|PubMed:2833478}. Note=The disease
CC       may be caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Alpha-thalassemia (A-THAL) [MIM:604131]: A form of
CC       thalassemia. Thalassemias are common monogenic diseases occurring
CC       mostly in Mediterranean and Southeast Asian populations. The hallmark
CC       of alpha-thalassemia is an imbalance in globin-chain production in the
CC       adult HbA molecule. The level of alpha chain production can range from
CC       none to very nearly normal levels. Deletion of both copies of each of
CC       the two alpha-globin genes causes alpha(0)-thalassemia, also known as
CC       homozygous alpha thalassemia. Due to the complete absence of alpha
CC       chains, the predominant fetal hemoglobin is a tetramer of gamma-chains
CC       (Bart hemoglobin) that has essentially no oxygen carrying capacity.
CC       This causes oxygen starvation in the fetal tissues leading to prenatal
CC       lethality or early neonatal death. The loss of two alpha genes results
CC       in mild alpha-thalassemia, also known as heterozygous alpha-
CC       thalassemia. Affected individuals have small red cells and a mild
CC       anemia (microcytosis). If three of the four alpha-globin genes are
CC       functional, individuals are completely asymptomatic. Some rare forms of
CC       alpha-thalassemia are due to point mutations (non-deletional alpha-
CC       thalassemia). Note=The disease is caused by mutations affecting the
CC       gene represented in this entry.
CC   -!- DISEASE: Note=Alpha(0)-thalassemia is associated with non-immune
CC       hydrops fetalis, a generalized edema of the fetus with fluid
CC       accumulation in the body cavities due to non-immune causes. Non-immune
CC       hydrops fetalis is not a diagnosis in itself but a symptom, a feature
CC       of many genetic disorders, and the end-stage of a wide variety of
CC       disorders.
CC   -!- DISEASE: Hemoglobin H disease (HBH) [MIM:613978]: A form of alpha-
CC       thalassemia due to the loss of three alpha genes. This results in high
CC       levels of a tetramer of four beta chains (hemoglobin H), causing a
CC       severe and life-threatening anemia. Untreated, most patients die in
CC       childhood or early adolescence. {ECO:0000269|PubMed:10569720}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: Gives blood its red color.
CC   -!- SIMILARITY: Belongs to the globin family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00238}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD97112.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=HbVar; Note=Human hemoglobin variants and
CC       thalassemias;
CC       URL="http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=directlink&gene=HBA1";
CC   -!- WEB RESOURCE: Name=HbVar; Note=Human hemoglobin variants and
CC       thalassemias;
CC       URL="http://globin.bx.psu.edu/cgi-bin/hbvar/query_vars3?mode=directlink&gene=HBA2";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=HBA1";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Hemoglobin entry;
CC       URL="https://en.wikipedia.org/wiki/Hemoglobin";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Journey into a tiny world
CC       - Issue 84 of July 2007;
CC       URL="https://web.expasy.org/spotlight/back_issues/084/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J00153; AAB59407.1; -; Genomic_DNA.
DR   EMBL; J00153; AAB59408.1; -; Genomic_DNA.
DR   EMBL; V00491; CAA23750.1; -; Genomic_DNA.
DR   EMBL; V00493; CAA23752.1; -; mRNA.
DR   EMBL; V00488; CAA23748.1; -; Genomic_DNA.
DR   EMBL; V00516; CAA23774.1; -; Genomic_DNA.
DR   EMBL; AF230076; AAF72612.1; -; Genomic_DNA.
DR   EMBL; AF525460; AAM83102.1; -; Genomic_DNA.
DR   EMBL; DQ431198; ABD95910.1; -; Genomic_DNA.
DR   EMBL; DQ431198; ABD95911.1; -; Genomic_DNA.
DR   EMBL; AF097635; AAC72839.1; -; mRNA.
DR   EMBL; AF105974; AAC97373.1; -; mRNA.
DR   EMBL; AF349571; AAK37554.1; -; mRNA.
DR   EMBL; AF536204; AAN04486.1; -; Genomic_DNA.
DR   EMBL; DQ499017; ABF56144.1; -; Genomic_DNA.
DR   EMBL; DQ499018; ABF56145.1; -; Genomic_DNA.
DR   EMBL; AK223392; BAD97112.1; ALT_INIT; mRNA.
DR   EMBL; AE006462; AAK61215.1; -; Genomic_DNA.
DR   EMBL; AE006462; AAK61216.1; -; Genomic_DNA.
DR   EMBL; Z84721; CAB06554.1; -; Genomic_DNA.
DR   EMBL; Z84721; CAB06555.1; -; Genomic_DNA.
DR   EMBL; BC005931; AAH05931.1; -; mRNA.
DR   EMBL; BC008572; AAH08572.1; -; mRNA.
DR   EMBL; BC032122; AAH32122.1; -; mRNA.
DR   EMBL; BC050661; AAH50661.1; -; mRNA.
DR   EMBL; BC101846; AAI01847.1; -; mRNA.
DR   EMBL; BC101848; AAI01849.1; -; mRNA.
DR   CCDS; CCDS10398.1; -.
DR   CCDS; CCDS10399.1; -.
DR   PIR; A90807; HAHU.
DR   PIR; C93303; HACZP.
DR   PIR; I58217; HACZ.
DR   RefSeq; NP_000508.1; NM_000517.4.
DR   RefSeq; NP_000549.1; NM_000558.4.
DR   PDB; 1A00; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1A01; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A0U; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1A0Z; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1A3N; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A3O; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1A9W; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1ABW; X-ray; 2.00 A; A=1-142.
DR   PDB; 1ABY; X-ray; 2.60 A; A=1-142.
DR   PDB; 1AJ9; X-ray; 2.20 A; A=2-142.
DR   PDB; 1B86; X-ray; 2.50 A; A/C=2-142.
DR   PDB; 1BAB; X-ray; 1.50 A; A/C=1-142.
DR   PDB; 1BBB; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1BIJ; X-ray; 2.30 A; A/C=2-142.
DR   PDB; 1BUW; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1BZ0; X-ray; 1.50 A; A/C=2-142.
DR   PDB; 1BZ1; X-ray; 1.59 A; A/C=1-142.
DR   PDB; 1BZZ; X-ray; 1.59 A; A/C=2-142.
DR   PDB; 1C7B; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1C7C; X-ray; 1.80 A; A=2-142.
DR   PDB; 1C7D; X-ray; 1.80 A; A=2-142.
DR   PDB; 1CLS; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1CMY; X-ray; 3.00 A; A/C=2-142.
DR   PDB; 1COH; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1DKE; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1DXT; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1DXU; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1DXV; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1FDH; X-ray; 2.50 A; A/B=2-142.
DR   PDB; 1FN3; X-ray; 2.48 A; A/C=2-142.
DR   PDB; 1G9V; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 1GBU; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1GBV; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1GLI; X-ray; 2.50 A; A/C=3-142.
DR   PDB; 1GZX; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HAB; X-ray; 2.30 A; A/C=2-142.
DR   PDB; 1HAC; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1HBA; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HBB; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1HBS; X-ray; 3.00 A; A/C/E/G=2-142.
DR   PDB; 1HCO; X-ray; 2.70 A; A=2-142.
DR   PDB; 1HDB; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1HGA; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HGB; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HGC; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1HHO; X-ray; 2.10 A; A=2-142.
DR   PDB; 1IRD; X-ray; 1.25 A; A=2-142.
DR   PDB; 1J3Y; X-ray; 1.55 A; A/C/E/G=2-142.
DR   PDB; 1J3Z; X-ray; 1.60 A; A/C/E/G=2-142.
DR   PDB; 1J40; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 1J41; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 1J7S; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1J7W; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1J7Y; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1JY7; X-ray; 3.20 A; A/C/P/R/U/W=2-142.
DR   PDB; 1K0Y; X-ray; 1.87 A; A/C=2-142.
DR   PDB; 1K1K; X-ray; 2.00 A; A=2-142.
DR   PDB; 1KD2; X-ray; 1.87 A; A/C=2-142.
DR   PDB; 1LFL; X-ray; 2.70 A; A/C/P/R=2-142.
DR   PDB; 1LFQ; X-ray; 2.60 A; A=2-142.
DR   PDB; 1LFT; X-ray; 2.60 A; A=2-142.
DR   PDB; 1LFV; X-ray; 2.80 A; A=2-142.
DR   PDB; 1LFY; X-ray; 3.30 A; A=2-142.
DR   PDB; 1LFZ; X-ray; 3.10 A; A=2-142.
DR   PDB; 1LJW; X-ray; 2.16 A; A=2-142.
DR   PDB; 1M9P; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1MKO; X-ray; 2.18 A; A/C=2-142.
DR   PDB; 1NEJ; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1NIH; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1NQP; X-ray; 1.73 A; A/C=2-142.
DR   PDB; 1O1I; X-ray; 2.30 A; A=2-142.
DR   PDB; 1O1J; X-ray; 1.90 A; A=2-142.
DR   PDB; 1O1K; X-ray; 2.00 A; A/C=3-142.
DR   PDB; 1O1L; X-ray; 1.80 A; A=2-142.
DR   PDB; 1O1M; X-ray; 1.85 A; A=2-142.
DR   PDB; 1O1N; X-ray; 1.80 A; A=2-142.
DR   PDB; 1O1O; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1O1P; X-ray; 1.80 A; A=2-142.
DR   PDB; 1QI8; X-ray; 1.80 A; A/C=3-142.
DR   PDB; 1QSH; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1QSI; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 1QXD; X-ray; 2.25 A; A/C=2-142.
DR   PDB; 1QXE; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 1R1X; X-ray; 2.15 A; A=2-142.
DR   PDB; 1R1Y; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1RPS; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RQ3; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1RQ4; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RQA; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1RVW; X-ray; 2.50 A; A=2-142.
DR   PDB; 1SDK; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1SDL; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1SHR; X-ray; 1.88 A; A/C=2-142.
DR   PDB; 1SI4; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1THB; X-ray; 1.50 A; A/C=2-142.
DR   PDB; 1UIW; X-ray; 1.50 A; A/C/E/G=2-142.
DR   PDB; 1VWT; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XXT; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1XY0; X-ray; 1.99 A; A/C=2-142.
DR   PDB; 1XYE; X-ray; 2.13 A; A/C=3-142.
DR   PDB; 1XZ2; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XZ4; X-ray; 2.00 A; A/C=3-142.
DR   PDB; 1XZ5; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1XZ7; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1XZU; X-ray; 2.16 A; A/C=2-142.
DR   PDB; 1XZV; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1Y01; X-ray; 2.80 A; B=1-142.
DR   PDB; 1Y09; X-ray; 2.25 A; A/C=2-142.
DR   PDB; 1Y0A; X-ray; 2.22 A; A/C=2-140.
DR   PDB; 1Y0C; X-ray; 2.30 A; A/C=2-140.
DR   PDB; 1Y0D; X-ray; 2.10 A; A/C=2-141.
DR   PDB; 1Y0T; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y0W; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y22; X-ray; 2.16 A; A/C=2-142.
DR   PDB; 1Y2Z; X-ray; 2.07 A; A/C=2-142.
DR   PDB; 1Y31; X-ray; 2.13 A; A/C=2-142.
DR   PDB; 1Y35; X-ray; 2.12 A; A/C=2-142.
DR   PDB; 1Y45; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1Y46; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1Y4B; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y4F; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1Y4G; X-ray; 1.91 A; A/C=2-142.
DR   PDB; 1Y4P; X-ray; 1.98 A; A/C=2-142.
DR   PDB; 1Y4Q; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1Y4R; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1Y4V; X-ray; 1.84 A; A/C=2-142.
DR   PDB; 1Y5F; X-ray; 2.14 A; A/C=2-142.
DR   PDB; 1Y5J; X-ray; 2.03 A; A/C=2-142.
DR   PDB; 1Y5K; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1Y7C; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y7D; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1Y7G; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1Y7Z; X-ray; 1.98 A; A/C=2-142.
DR   PDB; 1Y83; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 1Y85; X-ray; 2.13 A; A/C=2-142.
DR   PDB; 1Y8W; X-ray; 2.90 A; A/C=2-142.
DR   PDB; 1YDZ; X-ray; 3.30 A; A/C=2-140.
DR   PDB; 1YE0; X-ray; 2.50 A; A/C=2-142.
DR   PDB; 1YE1; X-ray; 4.50 A; A/C=2-142.
DR   PDB; 1YE2; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1YEN; X-ray; 2.80 A; A/C=2-142.
DR   PDB; 1YEO; X-ray; 2.22 A; A/C=2-142.
DR   PDB; 1YEQ; X-ray; 2.75 A; A/C=2-142.
DR   PDB; 1YEU; X-ray; 2.12 A; A/C=2-142.
DR   PDB; 1YEV; X-ray; 2.11 A; A/C=2-142.
DR   PDB; 1YFF; X-ray; 2.40 A; A/C/E/G=2-142.
DR   PDB; 1YG5; X-ray; 2.70 A; A/C=2-142.
DR   PDB; 1YGD; X-ray; 2.73 A; A/C=2-142.
DR   PDB; 1YGF; X-ray; 2.70 A; A/C=2-142.
DR   PDB; 1YH9; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 1YHE; X-ray; 2.10 A; A/C=2-142.
DR   PDB; 1YHR; X-ray; 2.60 A; A/C=2-142.
DR   PDB; 1YIE; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 1YIH; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 1YVQ; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 1YVT; X-ray; 1.80 A; A=2-142.
DR   PDB; 1YZI; X-ray; 2.07 A; A=2-142.
DR   PDB; 1Z8U; X-ray; 2.40 A; B/D=1-142.
DR   PDB; 2D5Z; X-ray; 1.45 A; A/C=2-142.
DR   PDB; 2D60; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 2DN1; X-ray; 1.25 A; A=2-142.
DR   PDB; 2DN2; X-ray; 1.25 A; A/C=2-142.
DR   PDB; 2DN3; X-ray; 1.25 A; A=2-142.
DR   PDB; 2DXM; Neutron; 2.10 A; A/C=2-142.
DR   PDB; 2H35; NMR; -; A/C=2-142.
DR   PDB; 2HBC; X-ray; 2.10 A; A=2-142.
DR   PDB; 2HBD; X-ray; 2.20 A; A=2-142.
DR   PDB; 2HBE; X-ray; 2.00 A; A=2-142.
DR   PDB; 2HBF; X-ray; 2.20 A; A=2-142.
DR   PDB; 2HBS; X-ray; 2.05 A; A/C/E/G=2-142.
DR   PDB; 2HCO; X-ray; 2.70 A; A=2-142.
DR   PDB; 2HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 2HHD; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 2HHE; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 2M6Z; NMR; -; A/C=2-142.
DR   PDB; 2W6V; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 2W72; X-ray; 1.07 A; A=2-142, C=3-142.
DR   PDB; 2YRS; X-ray; 2.30 A; A/C/I/M=2-142.
DR   PDB; 3B75; X-ray; 2.30 A; A/C/E/G/S=2-142.
DR   PDB; 3D17; X-ray; 2.80 A; A/C=2-142.
DR   PDB; 3D7O; X-ray; 1.80 A; A=2-142.
DR   PDB; 3DUT; X-ray; 1.55 A; A/C=2-142.
DR   PDB; 3HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 3HXN; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 3IA3; X-ray; 3.20 A; B/D=1-142.
DR   PDB; 3IC0; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3IC2; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 3KMF; Neutron; 2.00 A; A/E=2-142.
DR   PDB; 3NL7; X-ray; 1.80 A; A=2-142.
DR   PDB; 3NMM; X-ray; 1.60 A; A/C=2-142.
DR   PDB; 3ODQ; X-ray; 3.10 A; A/C=2-142.
DR   PDB; 3ONZ; X-ray; 2.09 A; A=2-142.
DR   PDB; 3OO4; X-ray; 1.90 A; A=2-142.
DR   PDB; 3OO5; X-ray; 2.10 A; A=2-142.
DR   PDB; 3OVU; X-ray; 2.83 A; C=2-142.
DR   PDB; 3P5Q; X-ray; 2.00 A; A=2-142.
DR   PDB; 3QJB; X-ray; 1.80 A; A=2-142.
DR   PDB; 3QJC; X-ray; 2.00 A; A=2-142.
DR   PDB; 3QJD; X-ray; 1.56 A; A/C=2-142.
DR   PDB; 3QJE; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3R5I; X-ray; 2.20 A; A/C=2-142.
DR   PDB; 3S48; X-ray; 3.05 A; C/D=2-142.
DR   PDB; 3S65; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 3S66; X-ray; 1.40 A; A=2-142.
DR   PDB; 3SZK; X-ray; 3.01 A; A/D=2-142.
DR   PDB; 3WCP; X-ray; 1.94 A; A/C=2-142.
DR   PDB; 3WHM; X-ray; 1.85 A; A/E=2-142.
DR   PDB; 4FC3; X-ray; 2.26 A; A=2-142.
DR   PDB; 4HHB; X-ray; 1.74 A; A/C=2-142.
DR   PDB; 4IJ2; X-ray; 4.24 A; A/C=2-142.
DR   PDB; 4L7Y; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 4M4A; X-ray; 2.05 A; A=2-142.
DR   PDB; 4M4B; X-ray; 2.00 A; A=2-142.
DR   PDB; 4MQC; X-ray; 2.20 A; A=2-142.
DR   PDB; 4MQG; X-ray; 1.68 A; A=2-142.
DR   PDB; 4MQH; X-ray; 2.50 A; A=2-140.
DR   PDB; 4MQI; X-ray; 1.92 A; A=2-141.
DR   PDB; 4MQJ; X-ray; 1.80 A; A/C/E/G=2-142.
DR   PDB; 4MQK; X-ray; 2.24 A; A/C/E/G=2-142.
DR   PDB; 4N7N; X-ray; 2.75 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N7O; X-ray; 2.50 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N7P; X-ray; 2.81 A; A/C/E/G/I/K=2-142.
DR   PDB; 4N8T; X-ray; 1.90 A; A=2-142.
DR   PDB; 4NI0; X-ray; 2.15 A; A=2-142.
DR   PDB; 4NI1; X-ray; 1.90 A; A=2-142.
DR   PDB; 4ROL; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 4ROM; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 4WJG; X-ray; 3.10 A; A/F/K/P/U/Z=2-142.
DR   PDB; 4X0L; X-ray; 2.05 A; A=2-142.
DR   PDB; 4XS0; X-ray; 2.55 A; A=2-142.
DR   PDB; 5E29; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 5E6E; X-ray; 1.76 A; A=2-142.
DR   PDB; 5E83; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 5EE4; X-ray; 2.30 A; C/E=2-142.
DR   PDB; 5HU6; X-ray; 2.90 A; A=2-142.
DR   PDB; 5HY8; X-ray; 2.30 A; A/C/E/G/S=2-142.
DR   PDB; 5JDO; X-ray; 3.20 A; C=2-142, E=2-141.
DR   PDB; 5KDQ; X-ray; 2.15 A; A/C=3-142.
DR   PDB; 5KSI; X-ray; 1.80 A; A/C=2-142.
DR   PDB; 5KSJ; X-ray; 2.40 A; A/C=2-142.
DR   PDB; 5NI1; EM; 3.20 A; A/C=2-142.
DR   PDB; 5SW7; X-ray; 1.85 A; A=2-142.
DR   PDB; 5U3I; X-ray; 1.95 A; A/C=2-142.
DR   PDB; 5UCU; X-ray; 1.80 A; A=2-142.
DR   PDB; 5UFJ; X-ray; 2.05 A; A/C=2-142.
DR   PDB; 5URC; X-ray; 1.85 A; A/C=2-142.
DR   PDB; 5VMM; X-ray; 3.60 A; A/C=2-142.
DR   PDB; 5WOG; X-ray; 1.54 A; A/B=3-139.
DR   PDB; 5WOH; X-ray; 1.58 A; A/C=3-139.
DR   PDB; 5X2R; X-ray; 2.70 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2S; X-ray; 2.39 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2T; X-ray; 2.64 A; A/C/E/G/I/K=2-142.
DR   PDB; 5X2U; X-ray; 2.53 A; A/C/E/G/I/K=2-142.
DR   PDB; 6BB5; X-ray; 2.28 A; A=3-141.
DR   PDB; 6BNR; X-ray; 1.95 A; A/C=2-142.
DR   PDB; 6BWP; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 6BWU; X-ray; 2.00 A; A=2-142.
DR   PDB; 6DI4; X-ray; 1.90 A; A/C=2-142.
DR   PDB; 6HAL; X-ray; 2.20 A; A/C=3-141.
DR   PDB; 6HBW; X-ray; 2.00 A; A/C=2-142.
DR   PDB; 6HK2; X-ray; 1.55 A; A/C=2-142.
DR   PDB; 6KA9; X-ray; 1.40 A; A/C/E/G=2-142.
DR   PDB; 6KAE; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 6KAH; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 6KAI; X-ray; 1.45 A; A/C/E/G=2-142.
DR   PDB; 6KAO; X-ray; 1.40 A; A=2-142.
DR   PDB; 6KAP; X-ray; 1.45 A; A=2-142.
DR   PDB; 6KAQ; X-ray; 1.50 A; A=2-142.
DR   PDB; 6KAR; X-ray; 1.60 A; A=2-142.
DR   PDB; 6KAS; X-ray; 1.65 A; A/C=2-142.
DR   PDB; 6KAT; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 6KAU; X-ray; 1.60 A; A/C=2-142.
DR   PDB; 6KAV; X-ray; 1.70 A; A/C=2-142.
DR   PDB; 6KYE; X-ray; 2.28 A; A/C/E/G/I/K=1-142.
DR   PDB; 6L5V; X-ray; 1.45 A; A=2-142.
DR   PDB; 6L5W; X-ray; 1.50 A; A=2-142.
DR   PDB; 6L5X; X-ray; 1.65 A; A/C=2-142.
DR   PDB; 6L5Y; X-ray; 1.65 A; A/C=2-142.
DR   PDB; 6LCW; X-ray; 1.40 A; A/C/E/G=2-142.
DR   PDB; 6LCX; X-ray; 1.40 A; A/C/E/G=2-142.
DR   PDB; 6NBC; EM; 2.80 A; A/C=2-141.
DR   PDB; 6NBD; EM; 3.20 A; A/C=2-141.
DR   PDB; 6NQ5; X-ray; 1.85 A; A=2-142.
DR   PDB; 6TB2; X-ray; 2.90 A; A=2-142.
DR   PDBsum; 1A00; -.
DR   PDBsum; 1A01; -.
DR   PDBsum; 1A0U; -.
DR   PDBsum; 1A0Z; -.
DR   PDBsum; 1A3N; -.
DR   PDBsum; 1A3O; -.
DR   PDBsum; 1A9W; -.
DR   PDBsum; 1ABW; -.
DR   PDBsum; 1ABY; -.
DR   PDBsum; 1AJ9; -.
DR   PDBsum; 1B86; -.
DR   PDBsum; 1BAB; -.
DR   PDBsum; 1BBB; -.
DR   PDBsum; 1BIJ; -.
DR   PDBsum; 1BUW; -.
DR   PDBsum; 1BZ0; -.
DR   PDBsum; 1BZ1; -.
DR   PDBsum; 1BZZ; -.
DR   PDBsum; 1C7B; -.
DR   PDBsum; 1C7C; -.
DR   PDBsum; 1C7D; -.
DR   PDBsum; 1CLS; -.
DR   PDBsum; 1CMY; -.
DR   PDBsum; 1COH; -.
DR   PDBsum; 1DKE; -.
DR   PDBsum; 1DXT; -.
DR   PDBsum; 1DXU; -.
DR   PDBsum; 1DXV; -.
DR   PDBsum; 1FDH; -.
DR   PDBsum; 1FN3; -.
DR   PDBsum; 1G9V; -.
DR   PDBsum; 1GBU; -.
DR   PDBsum; 1GBV; -.
DR   PDBsum; 1GLI; -.
DR   PDBsum; 1GZX; -.
DR   PDBsum; 1HAB; -.
DR   PDBsum; 1HAC; -.
DR   PDBsum; 1HBA; -.
DR   PDBsum; 1HBB; -.
DR   PDBsum; 1HBS; -.
DR   PDBsum; 1HCO; -.
DR   PDBsum; 1HDB; -.
DR   PDBsum; 1HGA; -.
DR   PDBsum; 1HGB; -.
DR   PDBsum; 1HGC; -.
DR   PDBsum; 1HHO; -.
DR   PDBsum; 1IRD; -.
DR   PDBsum; 1J3Y; -.
DR   PDBsum; 1J3Z; -.
DR   PDBsum; 1J40; -.
DR   PDBsum; 1J41; -.
DR   PDBsum; 1J7S; -.
DR   PDBsum; 1J7W; -.
DR   PDBsum; 1J7Y; -.
DR   PDBsum; 1JY7; -.
DR   PDBsum; 1K0Y; -.
DR   PDBsum; 1K1K; -.
DR   PDBsum; 1KD2; -.
DR   PDBsum; 1LFL; -.
DR   PDBsum; 1LFQ; -.
DR   PDBsum; 1LFT; -.
DR   PDBsum; 1LFV; -.
DR   PDBsum; 1LFY; -.
DR   PDBsum; 1LFZ; -.
DR   PDBsum; 1LJW; -.
DR   PDBsum; 1M9P; -.
DR   PDBsum; 1MKO; -.
DR   PDBsum; 1NEJ; -.
DR   PDBsum; 1NIH; -.
DR   PDBsum; 1NQP; -.
DR   PDBsum; 1O1I; -.
DR   PDBsum; 1O1J; -.
DR   PDBsum; 1O1K; -.
DR   PDBsum; 1O1L; -.
DR   PDBsum; 1O1M; -.
DR   PDBsum; 1O1N; -.
DR   PDBsum; 1O1O; -.
DR   PDBsum; 1O1P; -.
DR   PDBsum; 1QI8; -.
DR   PDBsum; 1QSH; -.
DR   PDBsum; 1QSI; -.
DR   PDBsum; 1QXD; -.
DR   PDBsum; 1QXE; -.
DR   PDBsum; 1R1X; -.
DR   PDBsum; 1R1Y; -.
DR   PDBsum; 1RPS; -.
DR   PDBsum; 1RQ3; -.
DR   PDBsum; 1RQ4; -.
DR   PDBsum; 1RQA; -.
DR   PDBsum; 1RVW; -.
DR   PDBsum; 1SDK; -.
DR   PDBsum; 1SDL; -.
DR   PDBsum; 1SHR; -.
DR   PDBsum; 1SI4; -.
DR   PDBsum; 1THB; -.
DR   PDBsum; 1UIW; -.
DR   PDBsum; 1VWT; -.
DR   PDBsum; 1XXT; -.
DR   PDBsum; 1XY0; -.
DR   PDBsum; 1XYE; -.
DR   PDBsum; 1XZ2; -.
DR   PDBsum; 1XZ4; -.
DR   PDBsum; 1XZ5; -.
DR   PDBsum; 1XZ7; -.
DR   PDBsum; 1XZU; -.
DR   PDBsum; 1XZV; -.
DR   PDBsum; 1Y01; -.
DR   PDBsum; 1Y09; -.
DR   PDBsum; 1Y0A; -.
DR   PDBsum; 1Y0C; -.
DR   PDBsum; 1Y0D; -.
DR   PDBsum; 1Y0T; -.
DR   PDBsum; 1Y0W; -.
DR   PDBsum; 1Y22; -.
DR   PDBsum; 1Y2Z; -.
DR   PDBsum; 1Y31; -.
DR   PDBsum; 1Y35; -.
DR   PDBsum; 1Y45; -.
DR   PDBsum; 1Y46; -.
DR   PDBsum; 1Y4B; -.
DR   PDBsum; 1Y4F; -.
DR   PDBsum; 1Y4G; -.
DR   PDBsum; 1Y4P; -.
DR   PDBsum; 1Y4Q; -.
DR   PDBsum; 1Y4R; -.
DR   PDBsum; 1Y4V; -.
DR   PDBsum; 1Y5F; -.
DR   PDBsum; 1Y5J; -.
DR   PDBsum; 1Y5K; -.
DR   PDBsum; 1Y7C; -.
DR   PDBsum; 1Y7D; -.
DR   PDBsum; 1Y7G; -.
DR   PDBsum; 1Y7Z; -.
DR   PDBsum; 1Y83; -.
DR   PDBsum; 1Y85; -.
DR   PDBsum; 1Y8W; -.
DR   PDBsum; 1YDZ; -.
DR   PDBsum; 1YE0; -.
DR   PDBsum; 1YE1; -.
DR   PDBsum; 1YE2; -.
DR   PDBsum; 1YEN; -.
DR   PDBsum; 1YEO; -.
DR   PDBsum; 1YEQ; -.
DR   PDBsum; 1YEU; -.
DR   PDBsum; 1YEV; -.
DR   PDBsum; 1YFF; -.
DR   PDBsum; 1YG5; -.
DR   PDBsum; 1YGD; -.
DR   PDBsum; 1YGF; -.
DR   PDBsum; 1YH9; -.
DR   PDBsum; 1YHE; -.
DR   PDBsum; 1YHR; -.
DR   PDBsum; 1YIE; -.
DR   PDBsum; 1YIH; -.
DR   PDBsum; 1YVQ; -.
DR   PDBsum; 1YVT; -.
DR   PDBsum; 1YZI; -.
DR   PDBsum; 1Z8U; -.
DR   PDBsum; 2D5Z; -.
DR   PDBsum; 2D60; -.
DR   PDBsum; 2DN1; -.
DR   PDBsum; 2DN2; -.
DR   PDBsum; 2DN3; -.
DR   PDBsum; 2DXM; -.
DR   PDBsum; 2H35; -.
DR   PDBsum; 2HBC; -.
DR   PDBsum; 2HBD; -.
DR   PDBsum; 2HBE; -.
DR   PDBsum; 2HBF; -.
DR   PDBsum; 2HBS; -.
DR   PDBsum; 2HCO; -.
DR   PDBsum; 2HHB; -.
DR   PDBsum; 2HHD; -.
DR   PDBsum; 2HHE; -.
DR   PDBsum; 2M6Z; -.
DR   PDBsum; 2W6V; -.
DR   PDBsum; 2W72; -.
DR   PDBsum; 2YRS; -.
DR   PDBsum; 3B75; -.
DR   PDBsum; 3D17; -.
DR   PDBsum; 3D7O; -.
DR   PDBsum; 3DUT; -.
DR   PDBsum; 3HHB; -.
DR   PDBsum; 3HXN; -.
DR   PDBsum; 3IA3; -.
DR   PDBsum; 3IC0; -.
DR   PDBsum; 3IC2; -.
DR   PDBsum; 3KMF; -.
DR   PDBsum; 3NL7; -.
DR   PDBsum; 3NMM; -.
DR   PDBsum; 3ODQ; -.
DR   PDBsum; 3ONZ; -.
DR   PDBsum; 3OO4; -.
DR   PDBsum; 3OO5; -.
DR   PDBsum; 3OVU; -.
DR   PDBsum; 3P5Q; -.
DR   PDBsum; 3QJB; -.
DR   PDBsum; 3QJC; -.
DR   PDBsum; 3QJD; -.
DR   PDBsum; 3QJE; -.
DR   PDBsum; 3R5I; -.
DR   PDBsum; 3S48; -.
DR   PDBsum; 3S65; -.
DR   PDBsum; 3S66; -.
DR   PDBsum; 3SZK; -.
DR   PDBsum; 3WCP; -.
DR   PDBsum; 3WHM; -.
DR   PDBsum; 4FC3; -.
DR   PDBsum; 4HHB; -.
DR   PDBsum; 4IJ2; -.
DR   PDBsum; 4L7Y; -.
DR   PDBsum; 4M4A; -.
DR   PDBsum; 4M4B; -.
DR   PDBsum; 4MQC; -.
DR   PDBsum; 4MQG; -.
DR   PDBsum; 4MQH; -.
DR   PDBsum; 4MQI; -.
DR   PDBsum; 4MQJ; -.
DR   PDBsum; 4MQK; -.
DR   PDBsum; 4N7N; -.
DR   PDBsum; 4N7O; -.
DR   PDBsum; 4N7P; -.
DR   PDBsum; 4N8T; -.
DR   PDBsum; 4NI0; -.
DR   PDBsum; 4NI1; -.
DR   PDBsum; 4ROL; -.
DR   PDBsum; 4ROM; -.
DR   PDBsum; 4WJG; -.
DR   PDBsum; 4X0L; -.
DR   PDBsum; 4XS0; -.
DR   PDBsum; 5E29; -.
DR   PDBsum; 5E6E; -.
DR   PDBsum; 5E83; -.
DR   PDBsum; 5EE4; -.
DR   PDBsum; 5HU6; -.
DR   PDBsum; 5HY8; -.
DR   PDBsum; 5JDO; -.
DR   PDBsum; 5KDQ; -.
DR   PDBsum; 5KSI; -.
DR   PDBsum; 5KSJ; -.
DR   PDBsum; 5NI1; -.
DR   PDBsum; 5SW7; -.
DR   PDBsum; 5U3I; -.
DR   PDBsum; 5UCU; -.
DR   PDBsum; 5UFJ; -.
DR   PDBsum; 5URC; -.
DR   PDBsum; 5VMM; -.
DR   PDBsum; 5WOG; -.
DR   PDBsum; 5WOH; -.
DR   PDBsum; 5X2R; -.
DR   PDBsum; 5X2S; -.
DR   PDBsum; 5X2T; -.
DR   PDBsum; 5X2U; -.
DR   PDBsum; 6BB5; -.
DR   PDBsum; 6BNR; -.
DR   PDBsum; 6BWP; -.
DR   PDBsum; 6BWU; -.
DR   PDBsum; 6DI4; -.
DR   PDBsum; 6HAL; -.
DR   PDBsum; 6HBW; -.
DR   PDBsum; 6HK2; -.
DR   PDBsum; 6KA9; -.
DR   PDBsum; 6KAE; -.
DR   PDBsum; 6KAH; -.
DR   PDBsum; 6KAI; -.
DR   PDBsum; 6KAO; -.
DR   PDBsum; 6KAP; -.
DR   PDBsum; 6KAQ; -.
DR   PDBsum; 6KAR; -.
DR   PDBsum; 6KAS; -.
DR   PDBsum; 6KAT; -.
DR   PDBsum; 6KAU; -.
DR   PDBsum; 6KAV; -.
DR   PDBsum; 6KYE; -.
DR   PDBsum; 6L5V; -.
DR   PDBsum; 6L5W; -.
DR   PDBsum; 6L5X; -.
DR   PDBsum; 6L5Y; -.
DR   PDBsum; 6LCW; -.
DR   PDBsum; 6LCX; -.
DR   PDBsum; 6NBC; -.
DR   PDBsum; 6NBD; -.
DR   PDBsum; 6NQ5; -.
DR   PDBsum; 6TB2; -.
DR   SMR; P69905; -.
DR   BioGRID; 109289; 32.
DR   BioGRID; 109290; 49.
DR   ComplexPortal; CPX-2158; Hemoglobin HbA complex.
DR   ComplexPortal; CPX-2419; Hemoglobin HbA2 complex.
DR   ComplexPortal; CPX-2927; Hemoglobin E complex.
DR   ComplexPortal; CPX-2932; Hemoglobin HbF Variant 1 complex.
DR   ComplexPortal; CPX-2933; Hemoglobin HbF Variant 2 complex.
DR   DIP; DIP-35199N; -.
DR   IntAct; P69905; 64.
DR   MINT; P69905; -.
DR   STRING; 9606.ENSP00000322421; -.
DR   ChEMBL; CHEMBL2887; -.
DR   DrugBank; DB08632; 1,3,5-BENZENETRICARBOXYLIC ACID.
DR   DrugBank; DB08262; 2,6-dicarboxynaphthalene.
DR   DrugBank; DB07427; 2-[(2-methoxy-5-methylphenoxy)methyl]pyridine.
DR   DrugBank; DB08077; 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID.
DR   DrugBank; DB07428; 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine.
DR   DrugBank; DB02126; 4-Carboxycinnamic Acid.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB08486; Efaproxiral.
DR   DrugBank; DB09147; Ferric pyrophosphate.
DR   DrugBank; DB13995; Ferric pyrophosphate citrate.
DR   DrugBank; DB14490; Ferrous ascorbate.
DR   DrugBank; DB14491; Ferrous fumarate.
DR   DrugBank; DB14488; Ferrous gluconate.
DR   DrugBank; DB14501; Ferrous glycine sulfate.
DR   DrugBank; DB14489; Ferrous succinate.
DR   DrugBank; DB01592; Iron.
DR   DrugBank; DB00893; Iron Dextran.
DR   DrugBank; DB09146; Iron sucrose.
DR   DrugBank; DB00358; Mefloquine.
DR   DrugBank; DB09112; Nitrous acid.
DR   DrugBank; DB09140; Oxygen.
DR   DrugBank; DB06154; Pentaerythritol tetranitrate.
DR   DrugBank; DB07645; SEBACIC ACID.
DR   DrugBank; DB09517; Sodium ferric gluconate complex.
DR   DrugBank; DB14975; Voxelotor.
DR   DrugBank; DB01593; Zinc.
DR   DrugBank; DB14487; Zinc acetate.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugCentral; P69905; -.
DR   TCDB; 1.A.107.1.1; the pore-forming globin (globin) family.
DR   CarbonylDB; P69905; -.
DR   iPTMnet; P69905; -.
DR   PhosphoSitePlus; P69905; -.
DR   BioMuta; HBA1; -.
DR   DMDM; 57013850; -.
DR   DOSAC-COBS-2DPAGE; P69905; -.
DR   REPRODUCTION-2DPAGE; IPI00410714; -.
DR   SWISS-2DPAGE; P69905; -.
DR   UCD-2DPAGE; P69905; -.
DR   CPTAC; non-CPTAC-1129; -.
DR   CPTAC; non-CPTAC-1130; -.
DR   EPD; P69905; -.
DR   jPOST; P69905; -.
DR   MassIVE; P69905; -.
DR   MaxQB; P69905; -.
DR   PaxDb; P69905; -.
DR   PeptideAtlas; P69905; -.
DR   PRIDE; P69905; -.
DR   ProteomicsDB; 12639; -.
DR   ProteomicsDB; 57547; -.
DR   TopDownProteomics; P69905; -.
DR   Antibodypedia; 65596; 236 antibodies.
DR   Antibodypedia; 8893; 179 antibodies.
DR   DNASU; 3039; -.
DR   Ensembl; ENST00000251595; ENSP00000251595; ENSG00000188536.
DR   Ensembl; ENST00000320868; ENSP00000322421; ENSG00000206172.
DR   GeneID; 3039; -.
DR   GeneID; 3040; -.
DR   KEGG; hsa:3039; -.
DR   KEGG; hsa:3040; -.
DR   UCSC; uc002cfv.4; human.
DR   CTD; 3039; -.
DR   CTD; 3040; -.
DR   DisGeNET; 3039; -.
DR   DisGeNET; 3040; -.
DR   EuPathDB; HostDB:ENSG00000188536.12; -.
DR   EuPathDB; HostDB:ENSG00000206172.8; -.
DR   GeneCards; HBA1; -.
DR   GeneCards; HBA2; -.
DR   GeneReviews; HBA1; -.
DR   GeneReviews; HBA2; -.
DR   HGNC; HGNC:4823; HBA1.
DR   HGNC; HGNC:4824; HBA2.
DR   HPA; ENSG00000188536; Group enriched (blood, bone marrow).
DR   HPA; ENSG00000206172; Tissue enriched (bone).
DR   MalaCards; HBA1; -.
DR   MalaCards; HBA2; -.
DR   MIM; 140700; phenotype.
DR   MIM; 141800; gene+phenotype.
DR   MIM; 141850; gene.
DR   MIM; 141860; gene.
DR   MIM; 604131; phenotype.
DR   MIM; 613978; phenotype.
DR   neXtProt; NX_P69905; -.
DR   OpenTargets; ENSG00000188536; -.
DR   OpenTargets; ENSG00000206172; -.
DR   Orphanet; 98791; Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16.
DR   Orphanet; 163596; Hb Bart's hydrops fetalis.
DR   Orphanet; 93616; Hemoglobin H disease.
DR   Orphanet; 330041; Hemoglobin M disease.
DR   PharmGKB; PA29199; -.
DR   eggNOG; KOG3378; Eukaryota.
DR   eggNOG; COG1018; LUCA.
DR   GeneTree; ENSGT00940000154590; -.
DR   InParanoid; P69905; -.
DR   KO; K13822; -.
DR   OMA; FHHFDLS; -.
DR   OrthoDB; 1479834at2759; -.
DR   PhylomeDB; P69905; -.
DR   TreeFam; TF332328; -.
DR   Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide.
DR   Reactome; R-HSA-2168880; Scavenging of heme from plasma.
DR   SIGNOR; P69905; -.
DR   BioGRID-ORCS; 3039; 2 hits in 401 CRISPR screens.
DR   BioGRID-ORCS; 3040; 1 hit in 89 CRISPR screens.
DR   ChiTaRS; HBA1; human.
DR   ChiTaRS; HBA2; human.
DR   EvolutionaryTrace; P69905; -.
DR   GeneWiki; HBA2; -.
DR   GeneWiki; Hemoglobin,_alpha_1; -.
DR   GeneWiki; Hemoglobin,_alpha_2; -.
DR   Pharos; P69905; Tbio.
DR   PRO; PR:P69905; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P69905; protein.
DR   Bgee; ENSG00000188536; Expressed in blood and 90 other tissues.
DR   ExpressionAtlas; P69905; baseline and differential.
DR   Genevisible; P69905; HS.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022627; C:cytosolic small ribosomal subunit; IDA:UniProtKB.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0031838; C:haptoglobin-hemoglobin complex; IDA:BHF-UCL.
DR   GO; GO:0005833; C:hemoglobin complex; IDA:BHF-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IBA:GO_Central.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0043177; F:organic acid binding; IBA:GO_Central.
DR   GO; GO:0019825; F:oxygen binding; IBA:GO_Central.
DR   GO; GO:0005344; F:oxygen carrier activity; IBA:GO_Central.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0098869; P:cellular oxidant detoxification; IEA:GOC.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IDA:BHF-UCL.
DR   GO; GO:0015671; P:oxygen transport; TAS:UniProtKB.
DR   GO; GO:0010942; P:positive regulation of cell death; IDA:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:BHF-UCL.
DR   CDD; cd08927; Hb-alpha_like; 1.
DR   Gene3D; 1.10.490.10; -; 1.
DR   InterPro; IPR000971; Globin.
DR   InterPro; IPR009050; Globin-like_sf.
DR   InterPro; IPR012292; Globin/Proto.
DR   InterPro; IPR002338; Haemoglobin_a-typ.
DR   InterPro; IPR002339; Haemoglobin_pi.
DR   Pfam; PF00042; Globin; 1.
DR   PRINTS; PR00612; ALPHAHAEM.
DR   PRINTS; PR00815; PIHAEM.
DR   SUPFAM; SSF46458; SSF46458; 1.
DR   PROSITE; PS01033; GLOBIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Direct protein sequencing; Disease mutation;
KW   Glycation; Glycoprotein; Heme; Hereditary hemolytic anemia; Iron;
KW   Metal-binding; Oxygen transport; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:12665801,
FT                   ECO:0000269|PubMed:13872627, ECO:0000269|PubMed:13954546,
FT                   ECO:0000269|PubMed:14093912"
FT   CHAIN           2..142
FT                   /note="Hemoglobin subunit alpha"
FT                   /id="PRO_0000052653"
FT   METAL           59
FT                   /note="Iron (heme distal ligand)"
FT   METAL           88
FT                   /note="Iron (heme proximal ligand)"
FT   SITE            9..10
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            12
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   SITE            14..15
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            25..26
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            30..31
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            46..47
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            48..49
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            53..54
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            56..57
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            57
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   SITE            60..61
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            61
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   SITE            91
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   SITE            92..93
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            100
FT                   /note="Not glycated"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   SITE            107..108
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            109..110
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            122..123
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   SITE            134..135
FT                   /note="(Microbial infection) Cleavage; by N.americanus apr-
FT                   2"
FT                   /evidence="ECO:0000269|PubMed:12552433"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         8
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         9
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         12
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         17
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         25
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         36
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         41
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         109
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         125
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         135
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         138
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   MOD_RES         139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P01942"
FT   CARBOHYD        8
FT                   /note="N-linked (Glc) (glycation) lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   CARBOHYD        17
FT                   /note="N-linked (Glc) (glycation) lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   CARBOHYD        41
FT                   /note="N-linked (Glc) (glycation) lysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   CARBOHYD        62
FT                   /note="N-linked (Glc) (glycation) lysine"
FT                   /evidence="ECO:0000269|PubMed:7358733"
FT   VARIANT         2
FT                   /note="V -> E (in Thionville; O(2) affinity down;
FT                   dbSNP:rs33981821)"
FT                   /evidence="ECO:0000269|PubMed:1618774"
FT                   /id="VAR_002719"
FT   VARIANT         3
FT                   /note="L -> R (in ChongQing; O(2) affinity up;
FT                   dbSNP:rs36030576)"
FT                   /evidence="ECO:0000269|PubMed:6526652"
FT                   /id="VAR_002720"
FT   VARIANT         6
FT                   /note="A -> D (in J-Toronto; dbSNP:rs34090856)"
FT                   /id="VAR_002721"
FT   VARIANT         6
FT                   /note="A -> P (in Karachi; dbSNP:rs34751764)"
FT                   /id="VAR_002722"
FT   VARIANT         7
FT                   /note="D -> A (in Sawara; O(2) affinity up;
FT                   dbSNP:rs33986902)"
FT                   /evidence="ECO:0000269|PubMed:20980,
FT                   ECO:0000269|PubMed:4744335"
FT                   /id="VAR_002723"
FT   VARIANT         7
FT                   /note="D -> G (in Swan River; dbSNP:rs281864805)"
FT                   /evidence="ECO:0000269|PubMed:8745434"
FT                   /id="VAR_002724"
FT   VARIANT         7
FT                   /note="D -> N (in Dunn; O(2) affinity up;
FT                   dbSNP:rs33961916)"
FT                   /evidence="ECO:0000269|PubMed:478975,
FT                   ECO:0000269|PubMed:7435503"
FT                   /id="VAR_002725"
FT   VARIANT         7
FT                   /note="D -> V (in Ferndown; O(2) affinity up;
FT                   dbSNP:rs281864805)"
FT                   /evidence="ECO:0000269|PubMed:7238857"
FT                   /id="VAR_002726"
FT   VARIANT         7
FT                   /note="D -> Y (in Woodville; O(2) affinity up;
FT                   dbSNP:rs281864806)"
FT                   /evidence="ECO:0000269|PubMed:3754246"
FT                   /id="VAR_002727"
FT   VARIANT         8
FT                   /note="K -> E (in Kurosaki; dbSNP:rs34817956)"
FT                   /evidence="ECO:0000269|PubMed:7558876"
FT                   /id="VAR_002728"
FT   VARIANT         10
FT                   /note="N -> T (in Broomfield; dbSNP:rs281860608)"
FT                   /id="VAR_038149"
FT   VARIANT         12
FT                   /note="K -> E (in Anantharaj; dbSNP:rs33938574)"
FT                   /id="VAR_002729"
FT   VARIANT         13
FT                   /note="A -> D (in J-Paris 1/J-Aljezur; dbSNP:rs35615982)"
FT                   /id="VAR_002730"
FT   VARIANT         14
FT                   /note="A -> P (in Ravenscourt Park; causes alpha-
FT                   thalassemia; dbSNP:rs35331909)"
FT                   /id="VAR_038150"
FT   VARIANT         15
FT                   /note="W -> R (in Evanston; O(2) affinity up;
FT                   dbSNP:rs33964317)"
FT                   /evidence="ECO:0000269|PubMed:6725558,
FT                   ECO:0000269|PubMed:6882779"
FT                   /id="VAR_002731"
FT   VARIANT         16
FT                   /note="G -> R (in Ottawa/Siam; dbSNP:rs35816645)"
FT                   /id="VAR_002732"
FT   VARIANT         17
FT                   /note="K -> M (in Harbin; slightly unstable;
FT                   dbSNP:rs35210126)"
FT                   /evidence="ECO:0000269|PubMed:6526652"
FT                   /id="VAR_002733"
FT   VARIANT         17
FT                   /note="K -> N (in Beijing; dbSNP:rs281860648 and
FT                   dbSNP:rs281860619)"
FT                   /id="VAR_002734"
FT   VARIANT         19
FT                   /note="G -> D (in Al-Ain Abu Dhabi; dbSNP:rs35993097)"
FT                   /evidence="ECO:0000269|PubMed:1428941"
FT                   /id="VAR_002735"
FT   VARIANT         19
FT                   /note="G -> R (in Handsworth; dbSNP:rs34504387)"
FT                   /id="VAR_002736"
FT   VARIANT         20
FT                   /note="A -> D (in J-Kurosh)"
FT                   /id="VAR_002737"
FT   VARIANT         20
FT                   /note="A -> E (in J-Tashikuergan; dbSNP:rs35628685)"
FT                   /id="VAR_002738"
FT   VARIANT         21
FT                   /note="H -> Q (in Le Lamentin; dbSNP:rs41525149)"
FT                   /id="VAR_002739"
FT   VARIANT         21
FT                   /note="H -> R (in Hobart; dbSNP:rs33943087)"
FT                   /evidence="ECO:0000269|PubMed:3654264"
FT                   /id="VAR_002740"
FT   VARIANT         22
FT                   /note="A -> D (in J-Nyanza; dbSNP:rs11548605)"
FT                   /id="VAR_002741"
FT   VARIANT         22
FT                   /note="A -> P (in Fontainebleau; dbSNP:rs34324664)"
FT                   /id="VAR_002742"
FT   VARIANT         23
FT                   /note="G -> D (in J-Medellin; dbSNP:rs34608326)"
FT                   /id="VAR_002743"
FT   VARIANT         24
FT                   /note="E -> G (in Reims; slightly unstable;
FT                   dbSNP:rs33939421)"
FT                   /evidence="ECO:0000269|PubMed:2634669"
FT                   /id="VAR_002744"
FT   VARIANT         24
FT                   /note="E -> K (in Chad; dbSNP:rs281864819)"
FT                   /id="VAR_002745"
FT   VARIANT         25
FT                   /note="Y -> H (in Luxembourg; unstable; dbSNP:rs281864821)"
FT                   /evidence="ECO:0000269|PubMed:2599879"
FT                   /id="VAR_002746"
FT   VARIANT         27
FT                   /note="A -> E (in Shenyang; unstable; dbSNP:rs281864822)"
FT                   /evidence="ECO:0000269|PubMed:7161109"
FT                   /id="VAR_002747"
FT   VARIANT         27
FT                   /note="A -> V (in Campinas; dbSNP:rs281864822)"
FT                   /evidence="ECO:0000269|PubMed:14576901"
FT                   /id="VAR_025387"
FT   VARIANT         28
FT                   /note="E -> D (in Hekinan; dbSNP:rs281865556)"
FT                   /id="VAR_002748"
FT   VARIANT         28
FT                   /note="E -> G (in Fort Worth; dbSNP:rs281864823)"
FT                   /id="VAR_002749"
FT   VARIANT         28
FT                   /note="E -> V (in Spanish town; dbSNP:rs281864823)"
FT                   /evidence="ECO:0000269|PubMed:2752146"
FT                   /id="VAR_002750"
FT   VARIANT         31
FT                   /note="E -> K (in O-Padova; dbSNP:rs111033605)"
FT                   /id="VAR_002751"
FT   VARIANT         32
FT                   /note="R -> K (causes alpha-thalassemia;
FT                   dbSNP:rs281864543)"
FT                   /evidence="ECO:0000269|PubMed:11410421"
FT                   /id="VAR_025002"
FT   VARIANT         32
FT                   /note="R -> S (in Prato; unstable; dbSNP:rs111033606)"
FT                   /evidence="ECO:0000269|PubMed:486536"
FT                   /id="VAR_002752"
FT   VARIANT         35
FT                   /note="L -> R (in Queens/Ogi; dbSNP:rs281864825)"
FT                   /id="VAR_002753"
FT   VARIANT         38
FT                   /note="P -> PE (in Catonsville)"
FT                   /evidence="ECO:0000269|PubMed:8448109"
FT                   /id="VAR_002755"
FT   VARIANT         38
FT                   /note="P -> R (in Bourmedes; dbSNP:rs281864826)"
FT                   /id="VAR_002754"
FT   VARIANT         41
FT                   /note="K -> M (in Kanagawa; O(2) affinity up;
FT                   dbSNP:rs281864828)"
FT                   /evidence="ECO:0000269|PubMed:1634355"
FT                   /id="VAR_002756"
FT   VARIANT         42
FT                   /note="T -> S (in Miyano; O(2) affinity up;
FT                   dbSNP:rs281860623)"
FT                   /evidence="ECO:0000269|PubMed:2634665"
FT                   /id="VAR_002757"
FT   VARIANT         44
FT                   /note="F -> L (in Hirosaki; unstable; dbSNP:rs41491146)"
FT                   /evidence="ECO:0000269|PubMed:1182166"
FT                   /id="VAR_002758"
FT   VARIANT         45
FT                   /note="P -> L (in Milledgeville; O(2) affinity up;
FT                   dbSNP:rs33978134 and dbSNP:rs281864830)"
FT                   /evidence="ECO:0000269|PubMed:7213661"
FT                   /id="VAR_002759"
FT   VARIANT         45
FT                   /note="P -> R (in Kawachi; O(2) affinity up;
FT                   dbSNP:rs281864830)"
FT                   /evidence="ECO:0000269|PubMed:7068434"
FT                   /id="VAR_002760"
FT   VARIANT         46
FT                   /note="H -> Q (in Bari; dbSNP:rs281860624)"
FT                   /id="VAR_002761"
FT   VARIANT         46
FT                   /note="H -> R (in Fort de France; O(2) affinity up;
FT                   dbSNP:rs281864831)"
FT                   /evidence="ECO:0000269|PubMed:2752146"
FT                   /id="VAR_002762"
FT   VARIANT         48
FT                   /note="D -> A (in Cordele; unstable; dbSNP:rs281864833)"
FT                   /evidence="ECO:0000269|PubMed:6547117"
FT                   /id="VAR_002763"
FT   VARIANT         48
FT                   /note="D -> G (in Kokura; also in Umi/Michigan; unstable;
FT                   dbSNP:rs281864833)"
FT                   /evidence="ECO:0000269|PubMed:7068437"
FT                   /id="VAR_002764"
FT   VARIANT         48
FT                   /note="D -> H (in Hasharon/Sinai; unstable;
FT                   dbSNP:rs281864834)"
FT                   /evidence="ECO:0000269|PubMed:5780195"
FT                   /id="VAR_002765"
FT   VARIANT         48
FT                   /note="D -> Y (in Kurdistan; dbSNP:rs281864834)"
FT                   /evidence="ECO:0000269|PubMed:8195005"
FT                   /id="VAR_002766"
FT   VARIANT         49
FT                   /note="L -> R (in Montgomery; dbSNP:rs41392146)"
FT                   /evidence="ECO:0000269|PubMed:1115799"
FT                   /id="VAR_002767"
FT   VARIANT         50
FT                   /note="S -> R (in Savaria; dbSNP:rs41518249)"
FT                   /id="VAR_002768"
FT   VARIANT         51
FT                   /note="H -> R (in Aichi; slightly unstable;
FT                   dbSNP:rs281864835)"
FT                   /evidence="ECO:0000269|PubMed:6714429"
FT                   /id="VAR_002769"
FT   VARIANT         52
FT                   /note="G -> D (in J-Abidjan; dbSNP:rs281864836)"
FT                   /id="VAR_002770"
FT   VARIANT         52
FT                   /note="G -> R (in Russ; dbSNP:rs281864837)"
FT                   /id="VAR_002771"
FT   VARIANT         54
FT                   /note="A -> D (in J-Rovigo; unstable; dbSNP:rs281864838)"
FT                   /evidence="ECO:0000269|PubMed:4824923"
FT                   /id="VAR_002772"
FT   VARIANT         55
FT                   /note="Q -> R (in Hikoshima/Shimonoseki;
FT                   dbSNP:rs281864839)"
FT                   /id="VAR_002773"
FT   VARIANT         57
FT                   /note="K -> R (in Port Huron; dbSNP:rs281864841)"
FT                   /evidence="ECO:0000269|PubMed:1802882"
FT                   /id="VAR_002774"
FT   VARIANT         57
FT                   /note="K -> T (in Thailand; dbSNP:rs281864841)"
FT                   /id="VAR_002775"
FT   VARIANT         58
FT                   /note="G -> R (in L-Persian Gulf; dbSNP:rs281864843)"
FT                   /id="VAR_002776"
FT   VARIANT         59
FT                   /note="H -> Q (in Boghe; dbSNP:rs41378349)"
FT                   /evidence="ECO:0000269|PubMed:10569723"
FT                   /id="VAR_025388"
FT   VARIANT         59
FT                   /note="H -> Y (in M-Boston/M-Osaka; O(2) affinity down;
FT                   dbSNP:rs281864845)"
FT                   /evidence="ECO:0000269|PubMed:4521212"
FT                   /id="VAR_002777"
FT   VARIANT         60
FT                   /note="G -> D (in Adana; unstable; causes alpha-
FT                   thalassemia; dbSNP:rs28928878)"
FT                   /evidence="ECO:0000269|PubMed:8237999"
FT                   /id="VAR_002778"
FT   VARIANT         60
FT                   /note="G -> V (in Tottori; unstable; dbSNP:rs281864846)"
FT                   /evidence="ECO:0000269|PubMed:7275660"
FT                   /id="VAR_002779"
FT   VARIANT         61
FT                   /note="K -> N (in Zambia; dbSNP:rs281860659 and
FT                   dbSNP:rs111033598)"
FT                   /id="VAR_002780"
FT   VARIANT         61
FT                   /note="Missing (in Clinic; unstable; causes alpha-
FT                   thalassemia)"
FT                   /evidence="ECO:0000269|PubMed:10206681"
FT                   /id="VAR_002781"
FT   VARIANT         62
FT                   /note="K -> N (in J-Buda; dbSNP:rs33985574)"
FT                   /evidence="ECO:0000269|Ref.82"
FT                   /id="VAR_002782"
FT   VARIANT         62
FT                   /note="K -> T (in J-Anatolia; dbSNP:rs281865558)"
FT                   /id="VAR_002783"
FT   VARIANT         63
FT                   /note="V -> M (in Evans; unstable; dbSNP:rs41515649)"
FT                   /evidence="ECO:0000269|PubMed:2606724, ECO:0000269|Ref.11"
FT                   /id="VAR_002784"
FT   VARIANT         63
FT                   /note="Missing (in HBH; hemoglobin Aghia Sophia)"
FT                   /evidence="ECO:0000269|PubMed:10569720"
FT                   /id="VAR_066401"
FT   VARIANT         64
FT                   /note="A -> D (in Pontoise; unstable; dbSNP:rs34502246)"
FT                   /evidence="ECO:0000269|PubMed:849454"
FT                   /id="VAR_002785"
FT   VARIANT         65
FT                   /note="D -> Y (in Persepolis; dbSNP:rs33984024)"
FT                   /id="VAR_002786"
FT   VARIANT         69
FT                   /note="N -> K (in G-Philadelphia; dbSNP:rs1060339)"
FT                   /evidence="ECO:0000269|Ref.12"
FT                   /id="VAR_002787"
FT   VARIANT         72
FT                   /note="A -> E (in J-Habana; dbSNP:rs281864853)"
FT                   /id="VAR_002788"
FT   VARIANT         72
FT                   /note="A -> V (in Ozieri; dbSNP:rs281864853)"
FT                   /id="VAR_002789"
FT   VARIANT         73
FT                   /note="H -> R (in Daneskgah-Teheran; dbSNP:rs281864854)"
FT                   /id="VAR_002790"
FT   VARIANT         75
FT                   /note="D -> A (in Lille; dbSNP:rs281864856)"
FT                   /id="VAR_002791"
FT   VARIANT         75
FT                   /note="D -> G (in Chapel Hill; dbSNP:rs33921047)"
FT                   /id="VAR_002792"
FT   VARIANT         75
FT                   /note="D -> N (in G-Pest; dbSNP:rs281864857)"
FT                   /evidence="ECO:0000269|Ref.82"
FT                   /id="VAR_002793"
FT   VARIANT         76
FT                   /note="D -> A (in Duan; dbSNP:rs33991223)"
FT                   /id="VAR_002794"
FT   VARIANT         76
FT                   /note="D -> H (in Q-Iran; dbSNP:rs281864858)"
FT                   /id="VAR_002795"
FT   VARIANT         77
FT                   /note="M -> K (in Noko; dbSNP:rs33969953)"
FT                   /id="VAR_002796"
FT   VARIANT         77
FT                   /note="M -> T (in Aztec; dbSNP:rs33969953)"
FT                   /id="VAR_002797"
FT   VARIANT         78
FT                   /note="P -> R (in Guizhou; dbSNP:rs281864861)"
FT                   /id="VAR_002798"
FT   VARIANT         79
FT                   /note="N -> H (in Davenport; dbSNP:rs111033602)"
FT                   /evidence="ECO:0000269|PubMed:2101836"
FT                   /id="VAR_002799"
FT   VARIANT         79
FT                   /note="N -> K (in Stanleyville-2; dbSNP:rs281860607)"
FT                   /id="VAR_002800"
FT   VARIANT         80
FT                   /note="A -> G (in Singapore; dbSNP:rs281860603)"
FT                   /id="VAR_012662"
FT   VARIANT         81
FT                   /note="L -> R (in Ann Arbor; unstable; dbSNP:rs281864863)"
FT                   /evidence="ECO:0000269|PubMed:5033650"
FT                   /id="VAR_002801"
FT   VARIANT         82
FT                   /note="S -> C (in Nigeria; dbSNP:rs281864864)"
FT                   /id="VAR_002802"
FT   VARIANT         83
FT                   /note="A -> D (in Garden State; dbSNP:rs281864865)"
FT                   /id="VAR_002803"
FT   VARIANT         85
FT                   /note="S -> R (in Etobicoke; O(2) affinity up;
FT                   dbSNP:rs281860612)"
FT                   /evidence="ECO:0000269|PubMed:6874377"
FT                   /id="VAR_002804"
FT   VARIANT         86
FT                   /note="D -> V (in Inkster; O(2) affinity up;
FT                   dbSNP:rs41331747)"
FT                   /evidence="ECO:0000269|PubMed:4212045"
FT                   /id="VAR_002805"
FT   VARIANT         86
FT                   /note="D -> Y (in Atago; O(2) affinity up;
FT                   dbSNP:rs281864777)"
FT                   /evidence="ECO:0000269|PubMed:5115619"
FT                   /id="VAR_002806"
FT   VARIANT         87
FT                   /note="L -> R (in Moabit; unstable; dbSNP:rs281864866)"
FT                   /evidence="ECO:0000269|PubMed:108887"
FT                   /id="VAR_002807"
FT   VARIANT         88
FT                   /note="H -> N (in Auckland; unstable; dbSNP:rs281864868)"
FT                   /evidence="ECO:0000269|PubMed:9322075"
FT                   /id="VAR_002808"
FT   VARIANT         88
FT                   /note="H -> R (in Iwata; unstable; dbSNP:rs281864867)"
FT                   /id="VAR_002809"
FT   VARIANT         89
FT                   /note="A -> S (in Loire; O(2) affinity up;
FT                   dbSNP:rs35239527)"
FT                   /evidence="ECO:0000269|PubMed:3142772"
FT                   /id="VAR_002810"
FT   VARIANT         91
FT                   /note="K -> M (in Handa; O(2) affinity up;
FT                   dbSNP:rs281864873)"
FT                   /evidence="ECO:0000269|PubMed:6815131"
FT                   /id="VAR_002811"
FT   VARIANT         92
FT                   /note="L -> F (in dbSNP:rs281864494)"
FT                   /id="VAR_049272"
FT   VARIANT         92
FT                   /note="L -> P (in Port Phillip; unstable;
FT                   dbSNP:rs281864874)"
FT                   /evidence="ECO:0000269|PubMed:902765"
FT                   /id="VAR_002812"
FT   VARIANT         93
FT                   /note="R -> Q (in J-Cape Town; O(2) affinity up;
FT                   dbSNP:rs281864875)"
FT                   /evidence="ECO:0000269|PubMed:5091982,
FT                   ECO:0000269|PubMed:5988206"
FT                   /id="VAR_002813"
FT   VARIANT         93
FT                   /note="R -> W (in Cemenelum; O(2) affinity up;
FT                   dbSNP:rs281864876)"
FT                   /evidence="ECO:0000269|PubMed:8148419"
FT                   /id="VAR_020775"
FT   VARIANT         95
FT                   /note="D -> A (in Bassett; markedly reduced oxygen
FT                   affinity; dbSNP:rs281864879)"
FT                   /evidence="ECO:0000269|PubMed:15495251"
FT                   /id="VAR_025389"
FT   VARIANT         95
FT                   /note="D -> Y (in Setif; unstable; dbSNP:rs281864878)"
FT                   /evidence="ECO:0000269|PubMed:4667378"
FT                   /id="VAR_002814"
FT   VARIANT         96
FT                   /note="P -> A (in Denmark Hill; O(2) affinity up;
FT                   dbSNP:rs281864881)"
FT                   /evidence="ECO:0000269|PubMed:5085669"
FT                   /id="VAR_002815"
FT   VARIANT         96
FT                   /note="P -> T (in Godavari; O(2) affinity up;
FT                   dbSNP:rs281864881)"
FT                   /evidence="ECO:0000269|PubMed:9494044"
FT                   /id="VAR_002816"
FT   VARIANT         98
FT                   /note="N -> K (in Dallas; O(2) affinity up;
FT                   dbSNP:rs41338947)"
FT                   /evidence="ECO:0000269|PubMed:1390940"
FT                   /id="VAR_002817"
FT   VARIANT         100
FT                   /note="K -> E (in Turriff; dbSNP:rs281864882)"
FT                   /evidence="ECO:0000269|PubMed:1634357"
FT                   /id="VAR_002818"
FT   VARIANT         103
FT                   /note="S -> R (in Manitoba; slightly unstable;
FT                   dbSNP:rs41344646)"
FT                   /evidence="ECO:0000269|PubMed:6547932"
FT                   /id="VAR_002819"
FT   VARIANT         104
FT                   /note="H -> R (in Contaldo; unstable; dbSNP:rs63750752)"
FT                   /evidence="ECO:0000269|PubMed:6547932"
FT                   /id="VAR_002820"
FT   VARIANT         104
FT                   /note="H -> Y (in Charolles; dbSNP:rs63750073)"
FT                   /evidence="ECO:0000269|PubMed:10569723"
FT                   /id="VAR_025390"
FT   VARIANT         110
FT                   /note="L -> R (in Suan-Dok; unstable; causes alpha-
FT                   thalassemia; dbSNP:rs41479844)"
FT                   /evidence="ECO:0000269|PubMed:478977"
FT                   /id="VAR_002821"
FT   VARIANT         111
FT                   /note="A -> D (in Petah Tikva; unstable; causes alpha-
FT                   thalassemia; dbSNP:rs28928889)"
FT                   /evidence="ECO:0000269|PubMed:7470621"
FT                   /id="VAR_002822"
FT   VARIANT         113
FT                   /note="H -> D (in Hopkins-II; unstable; dbSNP:rs281864885)"
FT                   /evidence="ECO:0000269|PubMed:5288820"
FT                   /id="VAR_002823"
FT   VARIANT         114
FT                   /note="L -> H (in Twin Peaks; dbSNP:rs281860618)"
FT                   /id="VAR_002824"
FT   VARIANT         115
FT                   /note="P -> L (in Nouakchott; dbSNP:rs267607269)"
FT                   /id="VAR_002825"
FT   VARIANT         115
FT                   /note="P -> R (in Chiapas; dbSNP:rs267607269)"
FT                   /id="VAR_002826"
FT   VARIANT         115
FT                   /note="P -> S (in Melusine; dbSNP:rs281864887)"
FT                   /evidence="ECO:0000269|PubMed:8294199"
FT                   /id="VAR_002827"
FT   VARIANT         116
FT                   /note="A -> D (in J-Tongariki; dbSNP:rs281864888)"
FT                   /id="VAR_002828"
FT   VARIANT         117
FT                   /note="E -> A (in Ube-4; dbSNP:rs281864946)"
FT                   /id="VAR_002829"
FT   VARIANT         117
FT                   /note="E -> EHLPAE (in Zaire)"
FT                   /evidence="ECO:0000269|PubMed:1511986"
FT                   /id="VAR_002830"
FT   VARIANT         118
FT                   /note="F -> FI (in Phnom Penh)"
FT                   /evidence="ECO:0000269|PubMed:9452028"
FT                   /id="VAR_002831"
FT   VARIANT         119
FT                   /note="T -> TEFT (in Grady)"
FT                   /evidence="ECO:0000269|PubMed:4528583"
FT                   /id="VAR_002832"
FT   VARIANT         121
FT                   /note="A -> E (in J-Meerut/J-Birmingham; dbSNP:rs36075744)"
FT                   /evidence="ECO:0000269|PubMed:7713747"
FT                   /id="VAR_002833"
FT   VARIANT         122
FT                   /note="V -> M (in Owari; dbSNP:rs35187567)"
FT                   /id="VAR_002834"
FT   VARIANT         123
FT                   /note="H -> Q (in Westmead; dbSNP:rs41479347)"
FT                   /evidence="ECO:0000269|PubMed:1686260"
FT                   /id="VAR_002835"
FT   VARIANT         126
FT                   /note="L -> P (in Quong Sze; causes alpha-thalassemia;
FT                   dbSNP:rs41397847)"
FT                   /id="VAR_002836"
FT   VARIANT         126
FT                   /note="L -> R (in Plasencia; family with moderate
FT                   microcytosis and hypochromia; dbSNP:rs41397847)"
FT                   /evidence="ECO:0000269|PubMed:15921163"
FT                   /id="VAR_025391"
FT   VARIANT         127
FT                   /note="D -> G (in West One; dbSNP:rs33957766)"
FT                   /evidence="ECO:0000269|PubMed:14576901"
FT                   /id="VAR_025392"
FT   VARIANT         127
FT                   /note="D -> V (in Fukutomi; O(2) affinity up;
FT                   dbSNP:rs33957766)"
FT                   /evidence="ECO:0000269|PubMed:2079432"
FT                   /id="VAR_002837"
FT   VARIANT         127
FT                   /note="D -> Y (in Montefiore; O(2) affinity up;
FT                   dbSNP:rs33933481)"
FT                   /evidence="ECO:0000269|PubMed:8798486"
FT                   /id="VAR_002838"
FT   VARIANT         128
FT                   /note="K -> N (in Jackson; dbSNP:rs33972894)"
FT                   /id="VAR_002839"
FT   VARIANT         130
FT                   /note="L -> P (in Tunis-Bizerte; unstable; causes alpha-
FT                   thalassemia; dbSNP:rs281864889)"
FT                   /evidence="ECO:0000269|PubMed:7786798"
FT                   /id="VAR_002840"
FT   VARIANT         131
FT                   /note="A -> D (in Yuda; O(2) affinity down;
FT                   dbSNP:rs41528545)"
FT                   /evidence="ECO:0000269|PubMed:1428950"
FT                   /id="VAR_002842"
FT   VARIANT         131
FT                   /note="A -> P (in Sun Prairie; unstable; dbSNP:rs41529844)"
FT                   /evidence="ECO:0000269|PubMed:2079430"
FT                   /id="VAR_002841"
FT   VARIANT         132
FT                   /note="S -> P (in Questembert; highly unstable; causes
FT                   alpha-thalassemia; dbSNP:rs63751417)"
FT                   /evidence="ECO:0000269|PubMed:8493987"
FT                   /id="VAR_002843"
FT   VARIANT         134
FT                   /note="S -> R (in Val de Marne; O(2) affinity up;
FT                   dbSNP:rs56308100 and dbSNP:rs55948437)"
FT                   /evidence="ECO:0000269|PubMed:8294200"
FT                   /id="VAR_002844"
FT   VARIANT         136
FT                   /note="V -> E (in Pavie; dbSNP:rs63749809)"
FT                   /id="VAR_002845"
FT   VARIANT         137
FT                   /note="L -> M (in Chicago; dbSNP:rs41364652)"
FT                   /id="VAR_002846"
FT   VARIANT         137
FT                   /note="L -> P (in Bibba; unstable; causes alpha-
FT                   thalassemia; dbSNP:rs41469945)"
FT                   /evidence="ECO:0000269|PubMed:5440849"
FT                   /id="VAR_002847"
FT   VARIANT         137
FT                   /note="L -> R (in Toyama; dbSNP:rs41469945)"
FT                   /evidence="ECO:0000269|PubMed:2833478"
FT                   /id="VAR_035242"
FT   VARIANT         139
FT                   /note="S -> P (in Attleboro; O(2) affinity up;
FT                   dbSNP:rs63750801)"
FT                   /evidence="ECO:0000269|PubMed:2108715"
FT                   /id="VAR_002848"
FT   VARIANT         140
FT                   /note="K -> E (in Hanamaki; O(2) affinity up;
FT                   dbSNP:rs41361546)"
FT                   /evidence="ECO:0000269|PubMed:1634363"
FT                   /id="VAR_002849"
FT   VARIANT         140
FT                   /note="K -> T (in Tokoname; O(2) affinity up;
FT                   dbSNP:rs56348461)"
FT                   /evidence="ECO:0000269|PubMed:6188720"
FT                   /id="VAR_002850"
FT   VARIANT         141
FT                   /note="Y -> H (in Rouen/Ethiopia; O(2) affinity up;
FT                   dbSNP:rs55870409)"
FT                   /evidence="ECO:0000269|PubMed:1390944,
FT                   ECO:0000269|PubMed:1428951"
FT                   /id="VAR_002851"
FT   VARIANT         142
FT                   /note="R -> C (in Nunobiki; O(2) affinity up;
FT                   dbSNP:rs63750134)"
FT                   /evidence="ECO:0000269|PubMed:3973024"
FT                   /id="VAR_002852"
FT   VARIANT         142
FT                   /note="R -> H (in Suresnes; O(2) affinity up;
FT                   dbSNP:rs33935328)"
FT                   /evidence="ECO:0000269|PubMed:7410435"
FT                   /id="VAR_002854"
FT   VARIANT         142
FT                   /note="R -> L (in Legnano; O(2) affinity up;
FT                   dbSNP:rs33935328)"
FT                   /evidence="ECO:0000269|PubMed:7462179"
FT                   /id="VAR_002853"
FT   VARIANT         142
FT                   /note="R -> P (in Singapore; dbSNP:rs33935328)"
FT                   /id="VAR_002855"
FT   CONFLICT        10
FT                   /note="N -> H (in Ref. 13; BAD97112)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..18
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           19..21
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           22..36
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           38..43
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   STRAND          45..47
FT                   /evidence="ECO:0000244|PDB:1M9P"
FT   STRAND          50..52
FT                   /evidence="ECO:0000244|PDB:1NEJ"
FT   HELIX           54..72
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   TURN            73..75
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           77..80
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           82..90
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   TURN            91..93
FT                   /evidence="ECO:0000244|PDB:2M6Z"
FT   HELIX           97..113
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   TURN            115..117
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           120..138
FT                   /evidence="ECO:0000244|PDB:2W72"
FT   HELIX           139..141
FT                   /evidence="ECO:0000244|PDB:6HK2"
SQ   SEQUENCE   142 AA;  15258 MW;  15E13666573BBBAE CRC64;
     MVLSPADKTN VKAAWGKVGA HAGEYGAEAL ERMFLSFPTT KTYFPHFDLS HGSAQVKGHG
     KKVADALTNA VAHVDDMPNA LSALSDLHAH KLRVDPVNFK LLSHCLLVTL AAHLPAEFTP
     AVHASLDKFL ASVSTVLTSK YR
//